Original Article
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
N Engl J Med 2007; 356:1944-1956May 10, 2007
- Abstract
Background
Substantial molecular evidence suggests a role for human papillomavirus (HPV) in the pathogenesis of oropharyngeal squamous-cell carcinoma, but epidemiologic data have been inconsistent.
Methods
We performed a hospital-based, case–control study of 100 patients with newly diagnosed oropharyngeal cancer and 200 control patients without cancer to evaluate associations between HPV infection and oropharyngeal cancer. Multivariate logistic-regression models were used for case–control comparisons.
Results
A high lifetime number of vaginal-sex partners (26 or more) was associated with oropharyngeal cancer (odds ratio, 3.1; 95% confidence interval [CI], 1.5 to 6.5), as was a high lifetime number of oral-sex partners (6 or more) (odds ratio, 3.4; 95% CI, 1.3 to 8.8). The degree of association increased with the number of vaginal-sex and oral-sex partners (P values for trend, 0.002 and 0.009, respectively). Oropharyngeal cancer was significantly associated with oral HPV type 16 (HPV-16) infection (odds ratio, 14.6; 95% CI, 6.3 to 36.6), oral infection with any of 37 types of HPV (odds ratio, 12.3; 95% CI, 5.4 to 26.4), and seropositivity for the HPV-16 L1 capsid protein (odds ratio, 32.2; 95% CI, 14.6 to 71.3). HPV-16 DNA was detected in 72% (95% CI, 62 to 81) of 100 paraffin-embedded tumor specimens, and 64% of patients with cancer were seropositive for the HPV-16 oncoprotein E6, E7, or both. HPV-16 L1 seropositivity was highly associated with oropharyngeal cancer among subjects with a history of heavy tobacco and alcohol use (odds ratio, 19.4; 95% CI, 3.3 to 113.9) and among those without such a history (odds ratio, 33.6; 95% CI, 13.3 to 84.8). The association was similarly increased among subjects with oral HPV-16 infection, regardless of their tobacco and alcohol use. By contrast, tobacco and alcohol use increased the association with oropharyngeal cancer primarily among subjects without exposure to HPV-16.
Conclusions
Oral HPV infection is strongly associated with oropharyngeal cancer among subjects with or without the established risk factors of tobacco and alcohol use.
Media in This Article
Figure 1
Representative Case of Oropharyngeal Squamous-Cell Carcinoma That Was Positive for HPV-16 on In Situ Hybridization.Table 1
Explanatory Variables for Patients with Oropharyngeal Cancer and Control Patients.Article Activity
- Article
Infection with sexually transmitted human papillomavirus (HPV) is a cause of virtually all cervical cancers.1 Molecular evidence also provides support for a role for HPV, particularly HPV-16, in the pathogenesis of a subgroup of squamous-cell carcinomas of the head and neck.2 Genomic DNA of oncogenic HPV is detected in approximately 26% of all squamous-cell carcinomas of the head and neck worldwide,3 but the molecular evidence is most rigorous and consistent for oropharyngeal squamous-cell carcinoma, in which viral integration and the expression of viral oncogenes (E6 and E7) have been shown.4
The epidemiologic evidence of a causal role for HPV in a subgroup of squamous-cell carcinomas of the head and neck is less rigorous than the molecular evidence. The example of the relationship between HPV and cervical cancer5 indicates that high-risk sexual behavior and exposure to and infection with HPV will increase the risk of other cancers caused by HPV.6 Although each of these three factors has been found to increase the risk of squamous-cell carcinomas of the head and neck,7-14 no single study has shown an association of all three with the development of oropharyngeal cancer.
In this study, we focused exclusively on oropharyngeal cancer, for which the molecular evidence of a causal role for HPV is compelling. Strong epidemiologic data would provide additional support for a causal association between HPV and oropharyngeal cancers and might guide future cancer-prevention programs involving vaccination to prevent oral HPV infection or screening to detect it.
Methods
Patients
Our case–control study was nested within a longitudinal cohort study of patients with newly diagnosed squamous-cell carcinomas of the head and neck in the outpatient otolaryngology clinic of the Johns Hopkins Hospital in Baltimore from 2000 through 2005. Eligible case patients included those with a confirmed diagnosis of oropharyngeal squamous-cell carcinoma.
The control group consisted of patients without a history of cancer who were seen for benign conditions between 2000 and 2005 in the same clinic from which the case patients were enrolled (Table 1Table 1
Explanatory Variables for Patients with Oropharyngeal Cancer and Control Patients.). Subsequent to enrollment of a case, eligible control patients within the same sex and 5-year age categories were approached until two control patients were individually matched to each case patient. The study protocol was approved by the institutional review board of the Johns Hopkins Hospital. Written, informed consent was obtained from all patients.Data Collection
Specimens were collected from case patients before therapy and from control patients at enrollment. Oral-mucosal specimens were collected with the use of a saline oral rinse and 5 to 10 strokes of a cytology brush (Oral CDx, CDx Laboratories) on the posterior oropharyngeal wall. Serum samples were collected and stored at −80°C. For case patients, formalin-fixed, paraffin-embedded tumor specimens and, if possible, snap-frozen fresh tumor specimens were obtained for the detection of HPV.
All patients completed an audio, computer-assisted self-administered interview that obtained information about demographic characteristics, oral hygiene, medical history, family history of cancer, lifetime sexual behaviors, and lifetime history of marijuana, tobacco, and alcohol use (see the Supplementary Appendix, available with the full text of this article at www.nejm.org).
Laboratory Studies
In Situ Hybridization for HPV-16 Detection
We looked for HPV-16 in formalin-fixed and paraffin-embedded tumors from all case subjects, using in situ hybridization–catalyzed signal amplification for biotinylated probes (Dako GenPoint).15 The HPV-16-positive status of a tumor was defined as specific staining of tumor-cell nuclei for HPV-16.
DNA Purification and Analysis
DNA from oral specimens16 and fresh-frozen tumors17 from a subgroup of case subjects was purified as previously described. The tumor specimens were microdissected to ensure that more than 70% of the sample was DNA from the tumor.
We analyzed purified DNA for 37 types of HPV by means of a multiplex polymerase-chain-reaction (PCR) assay targeted to the L1 region of the viral genome, using PGMY09/11 L1 primer pools and primers for β-globin, followed by hybridization to a linear probe array (Roche Molecular Systems).18 The HPV-16 viral load in purified DNA from oral-mucosal specimens and fresh-frozen tumor specimens was determined with the use of a sensitive real-time PCR assay targeted to the E6 coding region.16,19 The viral load was reported for positive samples (those with ≥1 copy of the virus) and was adjusted to the total number of human cells tested with the use of a real-time PCR assay targeted to a single copy of a human gene (for endogenous retrovirus 3, ERV3).16
Serologic Analysis
Serum antibodies to the HPV-16 L1 protein were detected with the use of an enzyme-linked immunosorbent assay (ELISA) based on virus-like particles.20 Antibodies against HPV-16 E6 and E7 oncoproteins were detected with the use of ELISA and bacterially expressed full-length E6 or E7 as the antigen.21
Statistical Analysis
Cumulative alcohol use was calculated as follows. We defined a drink-equivalent as one 12-oz beer, one 6-oz glass of wine, one 3-oz mixed drink, or one 1.5-oz shot of liquor. The number of drink-equivalents per week was determined for each patient within each 5-year age interval and combined into a measure of lifetime alcohol use, defined as the number of years during which 15 or more drink-equivalents (hereafter called “drinks”) per week were consumed.
We calculated cumulative tobacco use in pack-years using information about the frequency of use (number of cigarettes, pipes, or cigars smoked per day) and duration of use (during 5-year age intervals) and accounting for gaps in use. Four cigars or five pipes per day were deemed equivalent to one pack of cigarettes in the calculation of pack-years.22
Unconditional and conditional multivariate logistic-regression models were used to estimate odds ratios and the associated 95% confidence intervals (CIs). Results from the unconditional and conditional models were similar, and the results from the unconditional models are presented. Final multivariate models were created through stepwise elimination of variables of interest from univariate analysis while biologically relevant variables were retained. Owing to the colinearity of sexual behaviors, the effect of each behavior on the risk of cancer was evaluated in separate multivariate models adjusted for alcohol use, tobacco use, presence or absence of a family history of head and neck cancer, oral hygiene, age, and sex. To evaluate trends in odds, ordinal variables were modeled as single, continuous, independent variables. Multiplicative interactions among exposure to HPV, tobacco use, and alcohol use were evaluated by including an interaction term in the regression model, and statistical significance was determined with the use of the likelihood-ratio test. For comparison of our results with those in previous reports,9,10 additive interactions were evaluated with the use of a synergy index, calculated as (odds ratio for tobacco or alcohol use and HPV−1)÷([odds ratio for tobacco or alcohol use+odds ratio for HPV]−2).23 The odds ratio for HPV was for either seropositivity or infection. Attributable risk was calculated as previously described.24 P values of less than 0.05 for associations were considered to indicate statistical significance. Stata 8.0 software (Stata) was used for all analyses.
Results
We enrolled 130 consecutive patients with newly diagnosed oropharyngeal cancer in the longitudinal cohort study from 2000 through 2005, and 100 patients (77%) agreed to participate in our nested case–control study. Case patients who declined enrollment were similar to those who were enrolled with regard to age, race or ethnic group, and anatomical site of the tumor but were more likely to be female (P=0.001). Approximately 70% of eligible control patients (200) agreed to participate.
In the univariate analysis, case and control patients were similar with regard to age, sex, race or ethnic group, and education, but case patients were more likely than control patients to live outside of Maryland (Table 1). A history of squamous-cell carcinoma of the head and neck in a first-degree relative, a history of cancer in a sibling, a history of oral papillomas, and poor long-term oral hygiene (some or complete tooth loss or infrequent toothbrushing) were all associated with oropharyngeal cancer (Table 1). A history of heavy tobacco use (20 pack-years or more), a history of heavy alcohol use (15 drinks or more per week for 15 years or more), and a history of regular marijuana use were also associated with oropharyngeal cancer (Table 1). Similar percentages of case and control patients had no history of tobacco or alcohol use (13% and 14%, respectively; odds ratio, 1.0; 95% CI, 0.5 to 1.9).
Certain kinds of sexual behavior were significantly associated with oropharyngeal cancer after adjustment for confounding variables (Table 2Table 2
Associations of Oropharyngeal Cancer with Sexual Behaviors.). The association with oropharyngeal cancer increased significantly with the number of vaginal-sex partners or oral-sex partners (P for trend=0.002 and 0.009, respectively) and was markedly elevated among patients with a high lifetime number of such partners (Table 2).Oropharyngeal cancer was also strongly associated with serologic measures of exposure to HPV-16 and with the presence of oral HPV infection (Table 3Table 3
Association of Oropharyngeal Cancer with Exposure to HPV and with Biomarkers of Cancer Associated with HPV-16.). Oropharyngeal cancer was significantly associated with seropositivity for the HPV-16 L1 capsid protein, a validated measure of lifetime HPV-16 exposure (odds ratio, 32.2; 95% CI, 14.6 to 71.3).25 The presence of an oral HPV-16 infection was strongly associated with oropharyngeal cancer (odds ratio, 14.6; 95% CI, 6.3 to 36.6), as was oral infection with any of 37 HPV types (odds ratio, 12.3; 95% CI, 5.4 to 26.4) (Table 3).To explore whether the association between sexual behaviors and oropharyngeal cancer could be explained by HPV-16 exposure, we reevaluated the associations using multivariate models after adjusting for HPV-16 L1 serologic status. In this analysis, sexual behaviors were no longer significantly associated with oropharyngeal cancer (data not shown). However, associations of sexual behaviors with oropharyngeal cancer became stronger when the analysis was restricted to patients with an HPV-16–positive tumor (Table 2). A high lifetime number of oral-sex or vaginal-sex partners, engagement in casual sex, early age at first intercourse, and infrequent use of condoms each were associated with HPV-16–positive oropharyngeal cancer (Table 2).
The association between HPV-16 exposure and oropharyngeal cancer was investigated among patients with varied use of tobacco and alcohol. The association was greatly increased among patients without a history of smoking or drinking who were seropositive for HPV-16 L1 (odds ratio, 44.8; 95% CI, 5.9 to 338.5) or had an oral HPV-16 infection (odds ratio, 43.7; 95% CI, 4.2 to 452.7). HPV-16 L1 seropositivity and oral HPV-16 infection were also highly associated with oropharyngeal cancer among patients with a history of heavy tobacco and alcohol use and those without such a history (Table 4Table 4
Odds Ratios for Associations of Oropharyngeal Cancer with Tobacco Use, Alcohol Use, Seropositivity for HPV-16, and Oral Infection with HPV-16.). Thus, measures of both lifetime and prevalent oral HPV-16 infection were associated with an increased risk of oropharyngeal cancer, whether or not there was a history of use of tobacco, alcohol, or both.We evaluated whether combined exposure to HPV and tobacco or alcohol further increased the odds that oropharyngeal cancer would develop. No evidence of synergy was found (Table 4, top): combined exposure to HPV and heavy tobacco and alcohol use was not additive (synergy index <1). Moreover, when the analysis was restricted to patients who were seropositive for the HPV-16 L1 protein, the odds of oropharyngeal cancer were not increased among heavy users of tobacco or alcohol (Table 4, bottom). By contrast, among patients who were seronegative for the HPV-16 L1 protein, the odds of oropharyngeal cancer were increased among heavy users of tobacco or alcohol, and the odds of oropharyngeal cancer were further increased among heavy users of both tobacco and alcohol (synergy index >1) (Table 4, bottom). Similar relationships were observed in patients with and those without the presence of an oral HPV-16 infection (Table 4). Therefore, tobacco and alcohol were important risk factors for oropharyngeal cancer, but they may not have acted as cofactors in HPV-mediated carcinogenesis in the oropharynx.
In the multivariate analysis, oropharyngeal cancer was independently associated with HPV-16 L1 seropositivity (odds ratio, 32.2; 95% CI, 14.6 to 71.3), poor dentition (odds ratio, 4.1; 95% CI, 1.6 to 10.6), infrequent toothbrushing (odds ratio, 6.9; 95% CI, 1.6 to 30.3), history of squamous-cell carcinomas of the head and neck in a first-degree family member (odds ratio, 5.4; 95% CI, 1.0 to 30.8), and heavy tobacco use (odds ratio, 2.5; 95% CI, 1.1 to 6.0) after adjustment for age, sex, and alcohol use. These factors were collectively estimated to be responsible for 90% of cases of oropharyngeal cancers (the attributable risk; 95% CI, 72 to 96), with 55% of cases (95% CI, 45 to 63) attributable to HPV-16 exposure alone.
The percentage of oropharyngeal cancers in which HPV-16 genomic DNA was detected by in situ hybridization was 72% (95% CI, 62 to 81) (Table 3 and Figure 1Figure 1
Representative Case of Oropharyngeal Squamous-Cell Carcinoma That Was Positive for HPV-16 on In Situ Hybridization.). Of the 60 specimens of available fresh-frozen tumor, 35 (58%; 95% CI, 45 to 71) were positive for HPV-16, with a median of 1.2 viral copies per cell (interquartile range, 0.02 to 11) analyzed. Five fresh-frozen specimens were positive for a high-risk type of HPV other than HPV-16 (two for HPV-33, one for HPV-35, and two for both HPV-33 and HPV-16).To corroborate the in situ data, we tested for serum antibodies against HPV-16 oncoprotein E6, E7, or both, which have high specificity but moderate sensitivity for the detection of invasive cancer associated with HPV-16.26 Such antibodies were found in 64% of the case patients and in 4% of the control patients (odds ratio, 58.4; 95% CI, 24.2 to 138.3; P<0.001) (Table 2).
Discussion
This epidemiologic study provides support for the association between HPV and a subgroup of oropharyngeal cancers. The strength of the evidence is underscored by the associations of high-risk sexual behaviors, oral HPV infection, and HPV-16 exposure (as determined from the results of serologic tests) with oropharyngeal cancer. Furthermore, we found that HPV-16 DNA was specifically localized to tumor-cell nuclei in 72% of 100 paraffin-embedded specimens of oropharyngeal cancers, a finding corroborated by the high prevalence of antibodies for HPV-16 oncoprotein E6, E7, or both (64%) in the patients with oropharyngeal cancer. Although a cause-and-effect relationship cannot be inferred from a single study, our findings confirm and extend those of other case–control studies.7-14 Our results are also consistent with a previous report of an increase in the subsequent risk of oropharyngeal cancer by a factor of 14 among HPV-16 L1 seropositive subjects,26 which provides strong evidence that exposure to HPV can precede the appearance of oropharyngeal cancer by 10 years or more.
The degree to which oral HPV infection may interact with tobacco use, alcohol use, or both to increase the risk of squamous-cell carcinomas of the head and neck has been unclear. A greater-than-additive risk has been reported, albeit inconsistently,8-10 for patients exposed to both HPV and tobacco9 and those exposed to both HPV and alcohol.10 We found that exposure to HPV increased the association with oropharyngeal cancer regardless of tobacco and alcohol use, but we uncovered no evidence of synergy between exposure to HPV and tobacco or alcohol use. For these reasons, our data suggest two distinct pathways for the development of oropharyngeal cancer: one driven predominantly by the carcinogenic effects of tobacco or alcohol (or both) and another by HPV-induced genomic instability.
Our data suggest that oral HPV infection is sexually acquired. Oral–genital contact was strongly associated with oropharyngeal cancer, but we cannot rule out transmission through direct mouth-to-mouth contact or other means. Certain sexual behaviors13,14 and a history of oral HPV infection7,10 were associated with an increased risk of squamous-cell carcinomas of the head and neck in previous studies in which 25% or more of the tumors from patients were positive for HPV DNA but not those in which less than 25% of the tumors from patients were positive for HPV DNA.8,9 Discrepant findings may be explained by the heterogeneity of the case populations, with variable percentages of cancer cases attributable primarily to tobacco and alcohol use, as compared with HPV infection. In our study, the heterogeneity of case patients was minimized by restricting enrollment to patients with oropharyngeal cancer, 90% of whom had tumors on the tonsil or base of the tongue.
Although HPV-16 alone accounts for more than 90% of cases of HPV-positive squamous-cell carcinomas of the head and neck,8 a more accurate and probably higher proportion might be found by testing for other types of HPV (e.g., types 18, 31, 33, and 35), which are infrequently detected in oropharyngeal cancers.
In our study, oropharyngeal cancer was independently associated with a family history of squamous-cell carcinoma of the head and neck and poor oral hygiene, findings that are consistent with other reports.27 The risk of cervical cancer is also increased in women with a family history of that cancer.28,29 Until specific genetic markers for the risk of an HPV-associated cancer are identified, familial aggregation due to shared environmental exposures cannot be ruled out as an explanation for these findings. Poor dentition,30,31 infrequent toothbrushing,31,32 and infrequent dental visits30,33 have been associated with an increased risk of squamous-cell carcinomas of the head and neck. Because tooth loss is commonly caused by chronic bacterial infections (e.g., periodontitis), it may serve as a surrogate for chronic infection and inflammation, which may be important in the pathogenesis of cancer. Particular coinfections in the cervix (e.g., infection with Chlamydia trachomatis) increase the risk of cancer,34 and our results suggest that bacterial coinfections could play a similar role in the oral region. The absence of data on diet, which is associated with the risk of squamous-cell carcinomas of the head and neck,35 is a limitation of our study but is unlikely to explain the observed associations with HPV infection.
The public health implications of our findings are underscored by the annual increases in the incidence of tonsillar and base-of-tongue cancers in the United States since 1973.36,37 The widespread oral sexual practices among adolescents may be a contributing factor in this increase.38 Our results and those of other studies provide a rationale for HPV vaccination in both boys and girls — since oropharyngeal cancers occur in men and women. If vaccination is as effective in preventing oral HPV-16 infection as it is in preventing cervical infection,39 a substantial reduction in the incidence of oropharyngeal cancer in vaccinated populations would provide the ultimate evidence of causality.
Supported in part by grants from the Damon Runyon Cancer Research Foundation (Clinical Investigator Award, to Dr. Gillison), the State of Maryland Cigarette Restitution Fund (to Dr. Gillison), the National Institute of Dental and Craniofacial Research (DE016631-01, to Dr. Gillison), and the National Institutes of Health (Training Grant T32AI50056, to Dr. D'Souza).
No potential conflict of interest relevant to this article was reported.
We thank Janell Alden, Nicole Benoit, Barbara Clayman, Erlinda Embuscado, Eleni Goshu, Megan Hyle, Zubair Khan, Katherine Locke, Elizabeth O'Leary, Catherine Pevtsova, Carolyn Plescia, and Weihong Xiao for their roles in data collection and laboratory analysis; Dr. Shanaz Begum for technical expertise; Dr. Elizabeth Garrett-Mayer for statistical advice; and Dr. David E. Symer for comments on the manuscript.
Source Information
From the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health (G.D.); the Departments of Pediatrics (R.V.), Otolaryngology–Head and Neck Surgery (C.F., W.M.K.), and Pathology (W.H.W.), Johns Hopkins Hospital; and the Division of Viral Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University (M.L.G.) — all in Baltimore; the Division of Cancer Prevention, National Cancer Institute, Bethesda, MD (A.R.K.); and the Infection and Cancer Control Program, German Cancer Research Center, Heidelberg, Germany (M.P.).
Address reprint requests to Dr. Gillison at Johns Hopkins University, Cancer Research Bldg. I, Rm. 3M 54A, 1650 Orleans St., Baltimore, MD 21231, or to gillima@jhmi.edu.
- References
References
1
Walboomers JM ,Jacobs MV ,Manos MM , et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
CrossRef | Web of Science | Medline2
Gillison ML ,Koch WM ,Capone RB , et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720
CrossRef | Web of Science | Medline3
Kreimer AR ,Clifford GM ,Boyle P ,Franceschi S . Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-475
CrossRef | Web of Science | Medline4
Gillison ML . Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004;31:744-754
CrossRef | Web of Science | Medline5
Bosch FX ,De Sanjose S . Human papillomavirus and cervical cancer -- burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13
Medline6
Gillison ML ,Shah KV . Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003;31:57-65
Medline7
Hansson BG ,Rosenquist K ,Antonsson A , et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol (Stockh) 2005;125:1337-1344
CrossRef | Web of Science | Medline8
Herrero R ,Castellsague X ,Pawlita M , et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95:1772-1783
CrossRef | Web of Science | Medline9
Schwartz SM ,Daling JR ,Doody DR , et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998;90:1626-1636
CrossRef | Web of Science | Medline10
Smith EM ,Ritchie JM ,Summersgill KF , et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004;96:449-455
CrossRef | Web of Science | Medline11
Dahlstrom KR ,Adler-Storthz K ,Etzel CJ , et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 2003;9:2620-2626
Web of Science | Medline12
Maden C ,Beckmann AM ,Thomas DB , et al. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 1992;135:1093-1102
Web of Science | Medline13
Smith EM ,Ritchie JM ,Summersgill KF , et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004;108:766-772
CrossRef | Web of Science | Medline14
Rosenquist K ,Wennerberg J ,Schildt EB ,Bladstrom A ,Goran Hansson B ,Andersson G . Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol (Stockh) 2005;125:1327-1336
CrossRef | Web of Science | Medline15
Huang CC ,Qiu JT ,Kashima ML ,Kurman RJ ,Wu TC . Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol 1998;11:971-977
Web of Science | Medline16
D'Souza G ,Sugar E ,Ruby W ,Gravitt P ,Gillison M . Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. J Clin Microbiol 2005;43:5526-5535
CrossRef | Web of Science | Medline17
Fearon ER ,Feinberg AP ,Hamilton SH ,Vogelstein B . Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature 1985;318:377-380
CrossRef | Web of Science | Medline18
Peyton CL ,Gravitt PE ,Hunt WC , et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001;183:1554-1564
CrossRef | Web of Science | Medline19
Gravitt PE ,Peyton C ,Wheeler C ,Apple R ,Higuchi R ,Shah KV . Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J Virol Methods 2003;112:23-33
CrossRef | Web of Science | Medline20
Viscidi RP ,Ahdieh-Grant L ,Clayman B , et al. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis 2003;187:194-205
CrossRef | Web of Science | Medline21
Sehr P ,Zumbach K ,Pawlita M . A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 2001;253:153-162
CrossRef | Web of Science | Medline22
Benhamou S ,Benhamou E ,Flamant R . Lung cancer risk associated with cigar and pipe smoking. Int J Cancer 1986;37:825-829
CrossRef | Web of Science | Medline23
Hosmer DW ,Lemeshow S . Confidence interval estimation of interaction. Epidemiology 1992;3:452-456
CrossRef | Web of Science | Medline24
Greenland S ,Drescher K . Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 1993;49:865-872
CrossRef | Web of Science | Medline25
Dillner J . The serological response to papillomaviruses. Semin Cancer Biol 1999;9:423-430
CrossRef | Web of Science | Medline26
Mork J ,Lie AK ,Glattre E , et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-1131
Full Text | Web of Science | Medline27
Brown LM ,Gridley G ,Diehl SR , et al. Family cancer history and susceptibility to oral carcinoma in Puerto Rico. Cancer 2001;92:2102-2108
CrossRef | Web of Science | Medline28
Hemminki K ,Li X ,Mutanen P . Familial risks in invasive and in situ cervical cancer by histological type. Eur J Cancer Prev 2001;10:83-89
CrossRef | Web of Science | Medline29
Zelmanowicz Ade M ,Schiffman M ,Herrero R , et al. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States. Int J Cancer 2005;116:599-605
CrossRef | Web of Science | Medline30
Bundgaard T ,Wildt J ,Frydenberg M ,Elbrond O ,Nielsen JE . Case-control study of squamous cell cancer of the oral cavity in Denmark. Cancer Causes Control 1995;6:57-67
CrossRef | Web of Science | Medline31
Zheng TZ ,Boyle P ,Hu HF , et al. Dentition, oral hygiene, and risk of oral cancer: a case-control study in Beijing, People's Republic of China. Cancer Causes Control 1990;1:235-241
CrossRef | Web of Science | Medline32
Moreno-Lopez LA ,Esparza-Gomez GC ,Gonzalez-Navarro A ,Cerero-Lapiedra R ,Gonzalez-Hernandez MJ ,Dominguez-Rojas V . Risk of oral cancer associated with tobacco smoking, alcohol consumption and oral hygiene: a case-control study in Madrid, Spain. Oral Oncol 2000;36:170-174
CrossRef | Web of Science | Medline33
Maier H ,Zoller J ,Herrmann A ,Kreiss M ,Heller WD . Dental status and oral hygiene in patients with head and neck cancer. Otolaryngol Head Neck Surg 1993;108:655-661
Web of Science | Medline34
Smith JS ,Bosetti C ,Munoz N , et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004;111:431-439
CrossRef | Web of Science | Medline35
Kreimer AR ,Randi G ,Herrero R ,Castellsague X ,La Vecchia C ,Franceschi S . Diet and body mass, and oral and oropharyngeal squamous cell carcinomas: analysis from the IARC multinational case-control study. Int J Cancer 2006;118:2293-2297
CrossRef | Web of Science | Medline36
Shiboski CH ,Schmidt BL ,Jordan RC . Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005;103:1843-1849
CrossRef | Web of Science | Medline37
Frisch M ,Hjalgrim H ,Jaeger AB ,Biggar RJ . Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 2000;11:489-495
CrossRef | Web of Science | Medline38
Mosher WD ,Chandra A ,Jones J . Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data 2005;362:1-55
Medline39
Harper DM ,Franco EL ,Wheeler CM , et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006;367:1247-1255
CrossRef | Web of Science | Medline
- Citing Articles (349)
Citing Articles
1
Katharine A. R. Price, Ezra E. Cohen. (2012) Current Treatment Options for Metastatic Head and Neck Cancer. Current Treatment Options in Oncology
CrossRef2
F. Sitas, S. Egger, M. I. Urban, P. R. Taylor, C. C. Abnet, P. Boffetta, D. L. O'Connell, D. C. Whiteman, P. Brennan, R. Malekzadeh, M. Pawlita, S. M. Dawsey, T. Waterboer, . (2012) InterSCOPE Study: Associations Between Esophageal Squamous Cell Carcinoma and Human Papillomavirus Serological Markers. JNCI Journal of the National Cancer Institute 104:2, 147-158
CrossRef3
Michelle L. Stock, Laurel M. Peterson, Amy E. Houlihan, Laura A. Walsh. (2012) Influence of Oral Sex and Oral Cancer Information on Young Adults' Oral Sexual-Risk Cognitions and Likelihood of HPV Vaccination. Journal of Sex Research1-8
CrossRef4
Simin Jamaly, Mehrdad Rakaee Khanehkenari, Raghavendra Rao, Geeta Patil, Suresh Thakur, Poongothai Ramaswamy, B. S. Ajaikumar, Rashmita Sahoo. (2012) Relationship between p53 overexpression, human papillomavirus infection, and lifestyle in Indian patients with head and neck cancers. Tumor Biology
CrossRef5
Amal Mansour, Marwa Ali, Hussein Helmy, Samar Kassim. (2012) Human papillomavirus-16 (HPV-16) infection association with CIAP-2 expression in head and neck cancer. Medical Oncology
CrossRef6
Xiaohong Iris Wang, Jaiyeola Thomas, Songlin Zhang. (2012) Changing trends in human papillomavirus–associated head and neck squamous cell carcinoma. Annals of Diagnostic Pathology 16:1, 7-12
CrossRef7
Parul Sinha, Henrietta L. Logan, William M. Mendenhall. (2012) Human papillomavirus, smoking, and head and neck cancer. American Journal of Otolaryngology 33:1, 130-136
CrossRef8
Shao Hui Huang, Bayardo Perez-Ordonez, Fei-Fei Liu, John Waldron, Jolie Ringash, Jonathan Irish, Bernard Cummings, Lillian L. Siu, John Kim, Ilan Weinreb, Andrew Hope, Patrick Gullane, Dale Brown, Willa Shi, Brian O’Sullivan. (2012) Atypical Clinical Behavior of p16-Confirmed HPV-Related Oropharyngeal Squamous Cell Carcinoma Treated With Radical Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 82:1, 276-283
CrossRef9
AE Sanders, GD Slade, LL Patton. (2012) National prevalence of oral HPV infection and related risk factors in the U.S. adult population. Oral Diseasesno-no
CrossRef10
Daniel Moualed, A. Qayyum, T. Price, A. Sharma, S. Mahendran. (2012) Bilateral synchronous tonsillar carcinoma: a case series and review of the literature. European Archives of Oto-Rhino-Laryngology 269:1, 255-259
CrossRef11
Richard A. Crosby, Ralph J. DiClemente, Laura F. Salazar, Rachel Nash, Sinead Younge, Sara Head. (2012) Human Papillomavirus Vaccine Intention Among College Men: What's Oral Sex Got to Do With It?. Journal of American College Health 60:1, 8-12
CrossRef12
Su-Feng Chen, Fu-Shun Yu, Yun-Ching Chang, Earl Fu, Shin Nieh, Yaoh-Shiang Lin. (2012) Role of human papillomavirus infection in carcinogenesis of oral squamous cell carcinoma with evidences of prognostic association. Journal of Oral Pathology & Medicine 41:1, 9-15
CrossRef13
Hisham Mehanna, Tom Beech, Tom Nicholson, Iman El-Hariry, Christopher McConkey, Vinidh Paleri, Sally Roberts, David W. Eisele. (2012) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head & Neckn/a-n/a
CrossRef14
Corey J. Langer. (2012) Exploring biomarkers in head and neck cancer. Cancern/a-n/a
CrossRef15
Alexandra V. Lucs, Benjamin Saltman, Christine H. Chung, Bettie M. Steinberg, David L. Schwartz, Jeffrey N. Myers. (2012) Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment. Head & Neckn/a-n/a
CrossRef16
Anu Wallecha, Chris French, Robert Petit, Reshma Singh, Ashok Amin, John Rothman. (2012) Lm-LLO-Based Immunotherapies and HPV-Associated Disease. Journal of Oncology 2012, 1-10
CrossRef17
Sei Young Lee. (2012) Methods for Detection of Human Papillomavirus in Head and Neck Cancer. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 55:1, 8
CrossRef18
Thiago Fonseca-Silva, Lucyana Conceição Farias, Claudio Marcelo Cardoso, Ludmilla Regina de Souza, Carlos Alberto de Carvalho Fraga, Marcos Vinícius Macedo de Oliveira, Lucas Oliveira Barros, Lucas Rodrigues Alves, Alfredo Maurício Batista De-Paula, Luciano Marques-Silva, Ricardo Santiago Gomez, André Luiz Sena Guimarães. (2012) Analysis of p16<sub><i>CDKN2A</i></sub> Methylation and HPV-16 Infection in Oral Mucosal Dysplasia. Pathobiology 79:2, 94-100
CrossRef19
Changqing Ma, James Lewis. (2011) Small Biopsy Specimens Reliably Indicate p16 Expression Status of Oropharyngeal Squamous Cell Carcinoma. Head and Neck Pathology
CrossRef20
G. Bebek, K. L. Bennett, P. Funchain, R. Campbell, R. Seth, J. Scharpf, B. Burkey, C. Eng. (2011) Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma. Human Molecular Genetics
CrossRef21
Justin A. Bishop, James J. Sciubba, William H. Westra. (2011) Squamous Cell Carcinoma of the Oral Cavity and Oropharynx. Surgical Pathology Clinics 4:4, 1127-1151
CrossRef22
Simon R. Best, Patrick K. Ha, Ray G. Blanco, John R. Saunders, Eva S. Zinreich, Marshall A. Levine, Sara I. Pai, Melissa Walker, Jaclyn Trachta, Karen Ulmer, Peter Murakami, Richard Thompson, Joseph A. Califano, Barbara P. Messing. (2011) Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma. Head & Neck 33:12, 1727-1734
CrossRef23
Beth Wadsworth, Jeffery M. Bumpous, Alvin W. Martin, Michael R. Nowacki, Alfred B. Jenson, Hanan Farghaly. (2011) Expression of p16 in Sinonasal Undifferentiated Carcinoma (SNUC) Without Associated Human Papillomavirus (HPV). Head and Neck Pathology 5:4, 349-354
CrossRef24
Ranee Mehra, Ilya G. Serebriiskii, Roland L. Dunbrack, Matthew K. Robinson, Barbara Burtness, Erica A. Golemis. (2011) Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer. Drug Resistance Updates 14:6, 260-279
CrossRef25
Sun-ju Byeon, Wook Youn Kim, Kyung Yeol Lee, Tae Sook Hwang, Young Ho Kim, Mee Soo Chang. (2011) Expression of the human homolog of discs, large homolog 1 (Drosophila) in normal epithelium, nodule, papilloma and invasive squamous cell carcinoma of larynx. Basic and Applied Pathology 4:4, 105-109
CrossRef26
Giang T. Nguyen, Marc Altshuler. (2011) Vaccine-Preventable Diseases and Foreign-Born Populations. Primary Care: Clinics in Office Practice 38:4, 633-642
CrossRef27
James S Lewis Jr, Raja A Khan, Ramya P Masand, Rebecca D Chernock, Qin Zhang, Nasser Said Al-Naief, Susan Muller, Jonathan B McHugh, Manju L Prasad, Margaret Brandwein-Gensler, Bayardo Perez-Ordonez, Samir K El-Mofty. (2011) Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma - a prospective cohort and interobserver variability study*. Histopathologyno-no
CrossRef28
Masayuki Kabeya, Reiko Furuta, Kazuyoshi Kawabata, Sugata Takahashi, Yuichi Ishikawa. (2011) Prevalence of human papillomavirus in mobile tongue cancer with particular reference to young patients. Cancer Scienceno-no
CrossRef29
Megan A. Smith, Jie-Bin Lew, Robert J. Walker, Julia M.L. Brotherton, Carolyn Nickson, Karen Canfell. (2011) The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine 29:48, 9112-9122
CrossRef30
Myriam Loyo, Jonas T. Johnson, William H. Westra, Simion I. Chiosea, Christine G. Gourin. (2011) Management of the “Violated Neck” in the era of chemoradiation. The Laryngoscope 121:11, 2349-2358
CrossRef31
A. Rodríguez-Caballero, D. Torres-Lagares, M. Robles-García, J. Pachón-Ibáñez, D. González-Padilla, J.L. Gutiérrez-Pérez. (2011) Cancer treatment-induced oral mucositis: a critical review. International Journal of Oral and Maxillofacial Surgery
CrossRef32
Fumihito Sato, Isao Oze, Daisuke Kawakita, Noriyuki Yamamoto, Hidemi Ito, Satoyo Hosono, Takeshi Suzuki, Takakazu Kawase, Hiroki Furue, Miki Watanabe, Shunzo Hatooka, Yasushi Yatabe, Yasuhisa Hasegawa, Masayuki Shinoda, Minoru Ueda, Kazuo Tajima, Hideo Tanaka, Keitaro Matsuo. (2011) Inverse association between toothbrushing and upper aerodigestive tract cancer risk in a Japanese population. Head & Neck 33:11, 1628-1637
CrossRef33
Martin Steinau, Deepa Reddy, Anitra Sumbry, David Reznik, Clifford J. Gunthel, Carlos del Rio, Jeffrey L. Lennox, Elizabeth R. Unger, Minh Ly T. Nguyen. (2011) Oral sampling and human papillomavirus genotyping in HIV-infected patients. Journal of Oral Pathology & Medicineno-no
CrossRef34
Justin A. Bishop, William H. Westra. (2011) Human Papillomavirus-Related Small Cell Carcinoma of the Oropharynx. The American Journal of Surgical Pathology 35:11, 1679-1684
CrossRef35
Zeyi Deng, Masahiro Hasegawa, Sen Matayoshi, Asanori Kiyuna, Yukashi Yamashita, Hiroyuki Maeda, Mikio Suzuki. (2011) Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in Okinawa, southern Japan. European Archives of Oto-Rhino-Laryngology 268:11, 1625-1631
CrossRef36
Vijayvel Jayaprakash, Mary Reid, Elizabeth Hatton, Mihai Merzianu, Nestor Rigual, James Marshall, Steve Gill, Jennifer Frustino, Gregory Wilding, Thom Loree, Saurin Popat, Maureen Sullivan. (2011) Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: A meta-analysis, 1985–2010. Oral Oncology 47:11, 1048-1054
CrossRef37
H. H. Sudhoff, H. P. Schwarze, D. Winder, L. Steinstraesser, Martin Görner, M. Stanley, P. K. C. Goon. (2011) Evidence for a causal association for HPV in head and neck cancers. European Archives of Oto-Rhino-Laryngology 268:11, 1541-1547
CrossRef38
Korntip Amornthatree, Hutcha Sriplung, Winyou Mitarnun, Wipawee Nittayananta. (2011) Impacts of HIV infection and long-term use of antiretroviral therapy on the prevalence of oral human papilloma virus type 16. Journal of Oral Pathology & Medicineno-no
CrossRef39
Susan P. McGorray, Yi Guo, Henrietta Logan. (2011) Trends in incidence of oral and pharyngeal carcinoma in Florida: 1981-2008. Journal of Public Health Dentistryno-no
CrossRef40
Keith Hunter, Eric Kenneth Parkinson, Nalin Thakker. (2011) An overview of the molecular pathology of head and neck cancer, and its clinical implications. Periodontology 2000 57:1, 132-149
CrossRef41
Heather Starmer, Giuseppe Sanguineti, Shanthi Marur, Christine G. Gourin. (2011) Multidisciplinary head and neck cancer clinic and adherence with speech pathology. The Laryngoscope 121:10, 2131-2135
CrossRef42
Joseph E. Tota, Myriam Chevarie-Davis, Lyndsay A. Richardson, Maaike deVries, Eduardo L. Franco. (2011) Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Preventive Medicine 53, S12-S21
CrossRef43
Gypsyamber D'Souza, Amanda Dempsey. (2011) The role of HPV in head and neck cancer and review of the HPV vaccine. Preventive Medicine 53, S5-S11
CrossRef44
Newell W. Johnson, Prasanna Jayasekara, A. A. Hemantha K. Amarasinghe. (2011) Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontology 2000 57:1, 19-37
CrossRef45
Arild Andrè Osthus, Anne K.H. Aarstad, Jan Olofsson, Hans J. Aarstad. (2011) Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: A prospective cohort study. Oral Oncology 47:10, 974-979
CrossRef46
Genevieve Andrews, Miriam Lango, Roger Cohen, Steven Feigenberg, Barbara Burtness, Ranee Mehra, Sidrah Ahmed, Nicos Nicolaou, John Gaughan, John A. Ridge. (2011) Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: The Fox Chase Cancer Center experience. Head & Neck 33:10, 1433-1440
CrossRef47
Darin A. Wick, John R. Webb. (2011) A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors. Vaccine 29:44, 7857-7866
CrossRef48
Hongbin Cao, Alice Banh, Shirley Kwok, Xiaoli Shi, Simon Wu, Trevor Krakow, Brian Khong, Brindha Bavan, Rajeev Bala, Benjamin A. Pinsky, Dimitrios Colevas, Nader Pourmand, Albert C. Koong, Christina S. Kong, Quynh-Thu Le. (2011) Quantitation of Human Papillomavirus DNA in Plasma of Oropharyngeal Carcinoma Patients. International Journal of Radiation Oncology*Biology*Physics
CrossRef49
Alyson Bessell, Anne-Marie Glenny, Susan Furness, Jan E Clarkson, Richard Oliver, David I Conway, Michaelina Macluskey, Sue Pavitt, Philip Sloan, Helen V Worthington, Alyson Bessell. 2011. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. .
CrossRef50
Daniel Weiss, Tuerker Basel, Florian Sachse, Andreas Braeuninger, Claudia Rudack. (2011) Promoter methylation of cyclin A1 is associated with human papillomavirus 16 induced head and neck squamous cell carcinoma independently of p53 mutation. Molecular Carcinogenesis 50:9, 680-688
CrossRef51
X. Dufour, A. Beby-Defaux, G. Agius, J. Lacau St Guily. (2011) HPV and head and neck cancer. European Annals of Otorhinolaryngology, Head and Neck Diseases
CrossRef52
Richard Shaw, Max Robinson. (2011) The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer. British Journal of Oral and Maxillofacial Surgery 49:6, 423-429
CrossRef53
D. Bottalico, Z. Chen, A. Dunne, J. Ostoloza, S. McKinney, C. Sun, N. F. Schlecht, M. Fatahzadeh, R. Herrero, M. Schiffman, R. D. Burk. (2011) The Oral Cavity Contains Abundant Known and Novel Human Papillomaviruses From the Betapapillomavirus and Gammapapillomavirus Genera. Journal of Infectious Diseases 204:5, 787-792
CrossRef54
Marie Lundberg, Ilmo Leivo, Kauko Saarilahti, Antti A. Mäkitie, Petri S. Mattila. (2011) Increased incidence of oropharyngeal cancer and p16 expression. Acta Oto-laryngologica 131:9, 1008-1011
CrossRef55
Raghav C. Dwivedi, Ravi C. Dwivedi, Rehan Kazi, Namita Kanwar, Christopher M. Nutting, Kevin J. Harrington, Peter H. Rhys-Evans. (2011) Should the treatment paradigms for oral and oropharyngeal cancers be changed now: the role of human papilloma virus?. ANZ Journal of Surgery 81:9, 581-583
CrossRef56
Gefter Thiago Batista Corrêa, Gabriela Alencar Bandeira, Bruna Gonçalves Cavalcanti, Carlos Alberto de Carvalho Fraga, Erivelton Pereira dos Santos, Thiago Fonseca Silva, Ricardo Santiago Gomez, André Luiz Sena Guimarães, Alfredo Maurício Batista De Paula. (2011) Association of −308 TNF-α promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncology 47:9, 888-894
CrossRef57
C. Wittekindt, S. Wagner, J.P. Klußmann. (2011) Humane Papillomaviren bei Kopf-Hals-Karzinomen. HNO 59:9, 885-892
CrossRef58
N. Agrawal, M. J. Frederick, C. R. Pickering, C. Bettegowda, K. Chang, R. J. Li, C. Fakhry, T.-X. Xie, J. Zhang, J. Wang, N. Zhang, A. K. El-Naggar, S. A. Jasser, J. N. Weinstein, L. Trevino, J. A. Drummond, D. M. Muzny, Y. Wu, L. D. Wood, R. H. Hruban, W. H. Westra, W. M. Koch, J. A. Califano, R. A. Gibbs, D. Sidransky, B. Vogelstein, V. E. Velculescu, N. Papadopoulos, D. A. Wheeler, K. W. Kinzler, J. N. Myers. (2011) Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1. Science 333:6046, 1154-1157
CrossRef59
T. V. Macfarlane, G. J. Macfarlane, N. S. Thakker, S. Benhamou, C. Bouchardy, W. Ahrens, H. Pohlabeln, P. Lagiou, A. Lagiou, X. Castellsague, A. Agudo, A. Slamova, J. Plzak, F. Merletti, L. Richiardi, R. Talamini, L. Barzan, K. Kjaerheim, C. Canova, L. Simonato, D. I. Conway, P. A. McKinney, P. Thomson, P. Sloan, A. Znaor, C. M. Healy, B. E. McCartan, M. Marron, P. Brennan. (2011) Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study. Annals of Oncology
CrossRef60
Amanda Psyrri, Eleni Boutati, Sofia Karageorgopoulou. (2011) Human papillomavirus in head and neck cancers. Anti-Cancer Drugs 22:7, 586-590
CrossRef61
David J. Sher, Tracy A. Balboni, Robert I. Haddad, Charles M. Norris, Marshall R. Posner, Lori J. Wirth, Laura A. Goguen, Donald Annino, Roy B. Tishler. (2011) Efficacy and Toxicity of Chemoradiotherapy Using Intensity-Modulated Radiotherapy for Unknown Primary of Head and Neck. International Journal of Radiation Oncology*Biology*Physics 80:5, 1405-1411
CrossRef62
A.A. Osthus, A.K.H. Aarstad, J. Olofsson, H.J. Aarstad. (2011) Health-Related Quality of Life Scores in long-term head and neck cancer survivors predict subsequent survival: a prospective cohort study. Clinical Otolaryngology 36:4, 361-368
CrossRef63
Erika E. Doxtader, Anna-Luise A. Katzenstein. (2011) The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases. Human Pathology
CrossRef64
Atsushi Kondoh, Ken-Ichi Takano, Takashi Kojima, Tsuyoshi Ohkuni, Ryuta Kamekura, Noriko Ogasawara, Mitsuru Go, Norimasa Sawada, Tetsuo Himi. (2011) Altered expression of claudin-1, claudin-7, and tricellulin regardless of human papilloma virus infection in human tonsillar squamous cell carcinoma. Acta Oto-laryngologica 131:8, 861-868
CrossRef65
Patrick Chi-pan Lau, Anthony Tak-cheung Chan. (2011) Novel therapeutic target for head and neck squamous cell carcinoma. Anti-Cancer Drugs 22:7, 665-673
CrossRef66
G. Maschmeyer, K. Koch, M. Jungehülsing. (2011) Kopf-Hals-Tumoren. best practice onkologie 6:4, 4-20
CrossRef67
Maria Blomberg, Ann Nielsen, Christian Munk, Susanne Krüger Kjaer. (2011) Trends in head and neck cancer incidence in Denmark, 1978-2007: Focus on human papillomavirus associated sites. International Journal of Cancer 129:3, 733-741
CrossRef68
Vincent K. Tuohy, Ritika Jaini. (2011) Prophylactic cancer vaccination by targeting functional non-self. Annals of Medicine 43:5, 356-365
CrossRef69
Sophie Paget-Bailly, Diane Cyr, Danièle Luce. (2011) Occupational exposures to asbestos, polycyclic aromatic hydrocarbons and solvents, and cancers of the oral cavity and pharynx: a quantitative literature review. International Archives of Occupational and Environmental Health
CrossRef70
Richard Jordan, Maura Gillison, Annemieke van Zante. (2011) Oropharyngeal Carcinoma. Pathology Case Reviews 16:4, 173-175
CrossRef71
Isabelle Heard. (2011) Human papillomavirus, cancer and vaccination. Current Opinion in HIV and AIDS 6:4, 297-302
CrossRef72
Krista Rodriguez-Bruno, M. Jafer Ali, Steven J. Wang. (2011) Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma. Head & Neck 33:7, 949-953
CrossRef73
Anna E. Arthur, Sonia A. Duffy, Gloria I. Sanchez, Stephen B. Gruber, Jeffrey E. Terrell, James R. Hebert, Emily Light, Carol R. Bradford, Nisha J. D’Silva, Thomas E. Carey, Gregory T. Wolf, Karen E. Peterson, Laura S. Rozek. (2011) Higher Micronutrient Intake Is Associated With Human Papillomavirus-Positive Head and Neck Cancer: A Case-Only Analysis. Nutrition and Cancer 63:5, 734-742
CrossRef74
Lalle Hammarstedt, Yunxia Lu, Linda Marklund, Tina Dalianis, Eva Munck-Wikland, Weimin Ye. (2011) Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden. Oral Oncology 47:7, 636-641
CrossRef75
Agnès Beby-Defaux, Xavier Dufour, Gérard Agius. (2011) Infections à papillomavirus humains (HPV) des voies aéro-digestives supérieures (VADS). Revue Francophone des Laboratoires 2011:434, 65-75
CrossRef76
Pernille Lassen, Jesper G. Eriksen, Annelise Krogdahl, Marianne Hamilton Therkildsen, Benedicte P. Ulhøi, Marie Overgaard, Lena Specht, Elo Andersen, Jørgen Johansen, Lisbeth J. Andersen, Cai Grau, Jens Overgaard. (2011) The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial. Radiotherapy and Oncology 100:1, 49-55
CrossRef77
Per Attner, Juan Du, Anders Näsman, Lalle Hammarstedt, Torbjörn Ramqvist, Johan Lindholm, Linda Marklund, Tina Dalianis, Eva Munck-Wikland. (2011) Human papillomavirus and survival in patients with base of tongue cancer. International Journal of Cancer 128:12, 2892-2897
CrossRef78
K S Anderson, J Wong, G D'Souza, A B Riemer, J Lorch, R Haddad, S I Pai, J Longtine, M McClean, J LaBaer, K T Kelsey, M Posner. (2011) Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. British Journal of Cancer 104:12, 1896-1905
CrossRef79
H Mawardi, S Elad, M E Correa, K Stevenson, S-B Woo, S Almazrooa, R Haddad, J H Antin, R Soiffer, N Treister. (2011) Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplantation 46:6, 884-891
CrossRef80
Heikki Irjala, Nayla Matar, Marc Remacle, Lawson Georges. (2011) Pharyngo-laryngeal examination with the narrow band imaging technology: early experience. European Archives of Oto-Rhino-Laryngology 268:6, 801-806
CrossRef81
Jean Lacau St Guily, Anne-Carole Jacquard, Jean-Luc Prétet, Julie Haesebaert, Agnès Beby-Defaux, Christine Clavel, Gérard Agius, Philippe Birembaut, Claire Okaïs, Yann Léocmach, Benoît Soubeyrand, Pierre Pradat, Didier Riethmuller, Christiane Mougin, François Denis. (2011) Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France—The EDiTH VI study. Journal of Clinical Virology 51:2, 100-104
CrossRef82
Kristina R. Dahlstrom, Guojun Li, Guillermo Tortolero-Luna, Qingyi Wei, Erich M. Sturgis. (2011) Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head & Neck 33:6, 847-855
CrossRef83
Andreas Dietz, Gunnar Wichmann. (2011) Head and neck cancer: effective prevention in youth and predictive diagnostics for personalised treatment strategies according to biological differences. The EPMA Journal 2:2, 241-249
CrossRef84
Shao Hui Huang, Tara Rosewall. (2011) Human Papillomavirus-related Oropharyngeal Carcinoma: Current Understanding and Enduring Uncertainties. Journal of Medical Imaging and Radiation Sciences 42:2, 86-94
CrossRef85
Daniel Weiss, Mario Koopmann, Claudia Rudack. (2011) Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head & Neck 33:6, 856-862
CrossRef86
Luisa Lina Villa. (2011) HPV prophylactic vaccination: The first years and what to expect from now. Cancer Letters 305:2, 106-112
CrossRef87
Shaherin Basith, Balachandran Manavalan, Gwang Lee, Sang Geon Kim, Sangdun Choi. (2011) Toll-like receptor modulators: a patent review (2006 – 2010). Expert Opinion on Therapeutic Patents 21:6, 927-944
CrossRef88
Rebecca Shanesmith, Richard A. Allen, William E. Moore, Douglas W. Kingma, Samuel K. Caughron, Elizabeth M. Gillies, Samuel T. Dunn. (2011) Comparison of 2 line blot assays for defining HPV genotypes in oral and oropharyngeal squamous cell carcinomas. Diagnostic Microbiology and Infectious Disease 70:2, 240-245
CrossRef89
Maurice Y. Mommaerts, Murray E. Foster, Karsten K.H. Gundlach. (2011) How to do clinical research in cranio-maxillo-facial surgery. Journal of Cranio-Maxillofacial Surgery
CrossRef90
Linda Morris Brown, David P. Check, Susan S. Devesa. (2011) Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes & Control 22:5, 753-763
CrossRef91
Silke Tribius, Anna S. Ihloff, Thorsten Rieckmann, Cordula Petersen, Markus Hoffmann. (2011) Impact of HPV status on treatment of squamous cell cancer of the oropharynx: What we know and what we need to know. Cancer Letters 304:2, 71-79
CrossRef92
Mohan Suntharalingam, Young Kwok, Olga Goloubeva, Arti Parekh, Rodney Taylor, Jeffrey Wolf, Ann Zimrin, Scott Strome, Robert Ord, Kevin J Cullen. (2011) Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics
CrossRef93
A. Psyrri, E. Cohen. (2011) Oropharyngeal cancer: clinical implications of the HPV connection. Annals of Oncology 22:5, 997-999
CrossRef94
MW Lingen, A Pinto, RA Mendes, R Franchini, R Czerninski, WM Tilakaratne, M Partridge, DE Peterson, S-B Woo. (2011) Genetics/epigenetics of oral premalignancy: current status and future research*. Oral Diseases 17, 7-22
CrossRef95
M H Chen, P M Chang, W Y Li, L T Hsiao, Y C Hong, C Y Liu, J P Gau, J H Liu, P M Chen, T J Chiou, C H Tzeng. (2011) High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan. Bone Marrow Transplantation 46:4, 567-572
CrossRef96
K. B. Ribeiro, J. E. Levi, M. Pawlita, S. Koifman, E. Matos, J. Eluf-Neto, V. Wunsch-Filho, M. P. Curado, O. Shangina, D. Zaridze, N. Szeszenia-Dabrowska, J. Lissowska, A. Daudt, A. Menezes, V. Bencko, D. Mates, L. Fernandez, E. Fabianova, T. Gheit, M. Tommasino, P. Boffetta, P. Brennan, T. Waterboer. (2011) Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. International Journal of Epidemiology 40:2, 489-502
CrossRef97
Carlin Callaway. (2011) Rethinking the Head and Neck Cancer Population. Clinical Journal of Oncology Nursing 15:2, 165-170
CrossRef98
Luis F. Barroso, Timothy Wilkin. (2011) Human Papillomavirus Vaccination in Males: The State of the Science. Current Infectious Disease Reports 13:2, 175-181
CrossRef99
Tatevik R. Broutian, Xin He, Maura L. Gillison. (2011) Automated high throughput DNA isolation for detection of human papillomavirus in oral rinse samples. Journal of Clinical Virology 50:4, 270-275
CrossRef100
S Syrjänen, G Lodi, I von Bültzingslöwen, A Aliko, P Arduino, G Campisi, S Challacombe, G Ficarra, C Flaitz, HM Zhou, H Maeda, C Miller, M Jontell. (2011) Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Diseases 17, 58-72
CrossRef101
Jae Hong No, Mi-Kyung Kim, Yong-Tark Jeon, Yong-Beom Kim, Yong-Sang Song. (2011) Human papillomavirus vaccine: Widening the scope for cancer prevention. Molecular Carcinogenesis 50:4, 244-253
CrossRef102
F. Turati, C. Galeone, C. La Vecchia, W. Garavello, A. Tavani. (2011) Coffee and cancers of the upper digestive and respiratory tracts: meta-analyses of observational studies. Annals of Oncology 22:3, 536-544
CrossRef103
Joseph A. Dake, James H. Price, Britney L. Ward, Philip J. Welch. (2011) Midwestern Rural Adolescents' Oral Sex Experience. Journal of School Health 81:3, 159-165
CrossRef104
Emily M. Plummer, Marianne Manchester. (2011) Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 3:2, 174-196
CrossRef105
Laura F. Salazar, Sara Head, Richard A. Crosby, Ralph J. DiClemente, Jessica McDermott Sales, Gina M. Wingood, Eve Rose. (2011) Personal and Social Influences Regarding Oral Sex Among African American Female Adolescents. Journal of Women's Health 20:2, 161-167
CrossRef106
Jørgen Slots, Henrik Slots. (2011) Bacterial and viral pathogens in saliva: disease relationship and infectious risk. Periodontology 2000 55:1, 48-69
CrossRef107
Adam Rogers, Mackenzie Waltke, Peter C Angeletti. (2011) Evolutionary variation of papillomavirus E2 protein and E2 binding sites. Virology Journal 8:1, 379
CrossRef108
Min-Chi Chen, Ping-Tsung Chen, Chunghuang Hubert Chan, Cheng-Ta Yang, Chih-Cheng Chen, Cih-En Huang, Chang-Hsien Lu, Kuan-Der Lee. (2011) Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site. Journal of Cancer Research and Clinical Oncology 137:1, 115-123
CrossRef109
Carolin M. Grimminger, Peter V. Danenberg. (2011) Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review. European Archives of Oto-Rhino-Laryngology 268:1, 5-16
CrossRef110
Cristina P. Rodriguez, David J. Adelstein, Lisa A. Rybicki, Jerrold P. Saxton, Robert R. Lorenz, Benjamin G. Wood, Joseph Scharpf, Denise I. Ives. (2011) Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck. Head & Neckn/a-n/a
CrossRef111
Adarsh Barwad, Swati Sood, Nalini Gupta, Arvind Rajwanshi, Naresh Panda, Radhika Srinivasan. (2011) Human papilloma virus associated head and neck cancer: A PCR based study. Diagnostic Cytopathologyn/a-n/a
CrossRef112
Edgar P. Simard, Elizabeth M. Ward, Rebecca Siegel, Ahmedin Jemal. (2011) Cancers with increasing incidence trends in the United States: 1999 through 2008. CA: A Cancer Journal for Cliniciansn/a-n/a
CrossRef113
Dyego Leandro Bezerra de Souza, Marianna de Camargo Cancela, María Milagros Bernal Pérez, Maria-Paula Curado. (2011) Trends in the incidence of oral cavity and oropharyngeal cancers in Spain. Head & Neckn/a-n/a
CrossRef114
Travis P. Schrank, Yimei Han, Heidi Weiss, Vicente A. Resto. (2011) Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States-Possible role for human papillomavirus in survival disparities. Head & Neck 33:1, 45-53
CrossRef115
Linda Marklund, Lalle Hammarstedt. (2011) Impact of HPV in Oropharyngeal Cancer. Journal of Oncology 2011, 1-6
CrossRef116
N. Gopalakrishna Iyer, Iain J. Nixon, Frank Palmer, Leslie Kim, Monica Whitcher, Nora Katabi, Ronald Ghossein, Jatin P. Shah, Snehal G. Patel, Ian Ganly. (2011) Surgical management of squamous cell carcinoma of the soft palate: Factors predictive of outcome. Head & Neckn/a-n/a
CrossRef117
Lindy A.M. Santegoets, Romy van Baars, Annelinde Terlou, Claudia Heijmans-Antonissen, Sigrid M.A. Swagemakers, Peter J. van der Spek, Patricia C. Ewing, Marc van Beurden, Willem I. van der Meijden, Theo J.M. Helmerhorst, Leen J. Blok. (2011) Different DNA damage and cell cycle checkpoint control in low- and high-risk human papillomavirus infections of the vulva. International Journal of Cancern/a-n/a
CrossRef118
F. Farshadpour, S. Konings, E. J. M Speel, G. J. Hordijk, R. Koole, M. van Blokland, P. J. Slootweg, J. A. Kummer. (2011) Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study regarding Tobacco and Alcohol Consumption. Pathology Research International 2011, 1-9
CrossRef119
Ravi Mehrotra, Nishant Sharma, Haldun Umudum, Koray Ceyhan, Türkan Rezanko, Zubair Baloch. (2011) The role of cytopathology in diagnosing HPV induced oropharyngeal lesions. Diagnostic Cytopathologyn/a-n/a
CrossRef120
Abul Kalam Azad, Isabelle Bairati, Elodie Samson, Dangxiao Cheng, Lu Cheng, Maryam Mirshams, Sevtap Savas, John Waldron, Changshu Wang, David Goldstein, Wei Xu, Francois Meyer, Geoffrey Liu. (2011) Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. Cancern/a-n/a
CrossRef121
Parul Sinha, James S. Lewis, Jay F. Piccirillo, Dorina Kallogjeri, Bruce H. Haughey. (2011) Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancern/a-n/a
CrossRef122
Justin A. Bishop, Zahra Maleki, Alexandra Valsamakis, Takenori Ogawa, Xiaofei Chang, Sara I. Pai, William H. Westra. (2011) Application of the Hybrid Capture 2 assay to squamous cell carcinomas of the head and neck. Cancer Cytopathologyn/a-n/a
CrossRef123
C. René Leemans, Boudewijn J. M. Braakhuis, Ruud H. Brakenhoff. (2011) The molecular biology of head and neck cancer. Nature Reviews Cancer 11:1, 9-22
CrossRef124
Dong M. Shin, Fadlo R. Khuri. (2011) Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck. Head & Neckn/a-n/a
CrossRef125
Perle Ernoux-Neufcoeur, Mohammad Arafa, Christine Decaestecker, Anaëlle Duray, Myriam Remmelink, Xavier Leroy, Michael Herfs, Joan Somja, Christophe E. Depuydt, Philippe Delvenne, Sven Saussez. (2011) Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology 137:1, 173-181
CrossRef126
Gurkan Bebek, Mohammed Orloff, Charis Eng. (2011) Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma. Journal of Clinical Bioinformatics 1:1, 21
CrossRef127
Yu-Min Liao, Charles Kim, Yun Yen. (2011) Mammalian target of rapamycin and head and neck squamous cell carcinoma. Head & Neck Oncology 3:1, 22
CrossRef128
Hongxia Ma, Li-E Wang, Zhensheng Liu, Erich M Sturgis, Qingyi Wei. (2011) Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck. BMC Cancer 11:1, 258
CrossRef129
Deidre O Turner, Shelley J Williams-Cocks, Ryan Bullen, Jeremy Catmull, Jesse Falk, Daniel Martin, Jarom Mauer, Annabel E Barber, Robert C Wang, Shawn L Gerstenberger, Karl Kingsley. (2011) High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study. BMC Oral Health 11:1, 28
CrossRef130
Douglas E Morse, Carmen M Vélez Vega, Walter J Psoter, Himilce Vélez, Carmen J Buxó, Linda S Baek, Augusto Elias, Melba Ayendez. (2011) Perspectives of San Juan healthcare practitioners on the detection deficit in oral premalignant and early cancers in Puerto Rico: a qualitative research study. BMC Public Health 11:1, 391
CrossRef131
Stephanie A. Michal, David J. Adelstein, Lisa A. Rybicki, Cristina P. Rodriguez, Jerrold P. Saxton, Benjamin G. Wood, Joseph Scharpf, Denise I. Ives. (2011) Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly. Head & Neckn/a-n/a
CrossRef132
Nabil F. Saba, Michael Goodman, Kevin Ward, Chris Flowers, Suresh Ramalingam, Taofeek Owonikoko, Amy Chen, William Grist, Trad Wadsworth, Jonathan J. Beitler, Fadlo R. Khuri, Dong M. Shin. (2011) Gender and Ethnic Disparities in Incidence and Survival of Squamous Cell Carcinoma of the Oral Tongue, Base of Tongue, and Tonsils: A Surveillance, Epidemiology and End Results Program-Based Analysis. Oncology 81:1, 12-20
CrossRef133
Estela Kaminagakura, Luísa Lina Villa, Maria Antonieta Andreoli, João Simão Sobrinho, José Guilherme Vartanian, Fernando Augusto Soares, Inês Nobuko Nishimoto, Rafael Rocha, Luiz Paulo Kowalski. (2011) High-risk human papillomavirus in oral squamous cell carcinoma of young patients. International Journal of Cancern/a-n/a
CrossRef134
Xiaohan Li, Keiji Kikuchi, Yasuo Takano. (2011) ING Genes Work as Tumor Suppressor Genes in the Carcinogenesis of Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2011, 1-11
CrossRef135
H.S. van Monsjou, M.L.F. van Velthuysen, M.W.M. van den Brekel, E.S. Jordanova, C.J.M. Melief, A.J.M. Balm. (2011) Human papillomavirus status in young patients with head and neck squamous cell carcinoma. International Journal of Cancern/a-n/a
CrossRef136
Christoph Bergmann, Hagen S Bachmann, Agnes Bankfalvi, Ramin Lotfi, Carolin Pütter, Clarissa A Wild, Patrick J Schuler, Jens Greve, Thomas K Hoffmann, Stephan Lang, André Scherag, Götz F Lehnerdt. (2011) Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas. Journal of Translational Medicine 9:1, 139
CrossRef137
Saverio G Parisi, Mario Cruciani, Renzo Scaggiante, Caterina Boldrin, Samantha Andreis, Federico Bello, Silvana Pagni, Andrea Barelli, Andrea Sattin, Carlo Mengoli, Giorgio Palù. (2011) Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. BMC Infectious Diseases 11:1, 150
CrossRef138
Bryn Nelson. (2010) A new front in the debate over HPV vaccines for boys. Cancer Cytopathology 118:6, 413-414
CrossRef139
Anne-Marie Glenny, Susan Furness, Helen V Worthington, David I Conway, Richard Oliver, Jan E Clarkson, Michaelina Macluskey, Sue Pavitt, Kelvin KW Chan, Paul Brocklehurst, The CSROC Expert Panel, Anne-Marie Glenny. 2010. Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy. .
CrossRef140
Nazia Hasan, Ari Pollack, Ilseung Cho. (2010) Infectious Causes of Colorectal Cancer. Infectious Disease Clinics of North America 24:4, 1019-1039
CrossRef141
Patrick S. Moore, Yuan Chang. (2010) Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nature Reviews Cancer 10:12, 878-889
CrossRef142
Mario Augusto Brondani. (2010) Café Discussions on Oral Sex, Oral Cancer, and HPV Infection: Summative Report. Archives of Sexual Behavior 39:6, 1453-1455
CrossRef143
Vikas Mehta, Guo-Pei Yu, Stimson P. Schantz. (2010) Population-based analysis of oral and oropharyngeal carcinoma: Changing trends of histopathologic differentiation, survival and patient demographics. The Laryngoscope 120:11, 2203-2212
CrossRef144
Hester S. van Monsjou, Alfons J.M. Balm, Michiel M. van den Brekel, Volkert B. Wreesmann. (2010) Oropharyngeal squamous cell carcinoma: A unique disease on the rise?. Oral Oncology 46:11, 780-785
CrossRef145
Anthony N. Snow, Jennifer Laudadio. (2010) Human Papillomavirus Detection in Head and Neck Squamous Cell Carcinomas. Advances in Anatomic Pathology 17:6, 394-403
CrossRef146
Anthony Prince, Julio Aguirre-Ghizo, Eric Genden, Marshall Posner, Andrew Sikora. (2010) Head and Neck Squamous Cell Carcinoma: New Translational Therapies. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:6, 684-699
CrossRef147
Debby Herbenick, Michael Reece, Vanessa Schick, Stephanie A. Sanders, Brian Dodge, J. Dennis Fortenberry. (2010) Sexual Behavior in the United States: Results from a National Probability Sample of Men and Women Ages 14-94. The Journal of Sexual Medicine 7, 255-265
CrossRef148
Richard Horner. (2010) Spread the word about mouth cancer. Vital 7:5, 47-49
CrossRef149
António Roldão, Maria Candida M Mellado, Leda R Castilho, Manuel JT Carrondo, Paula M Alves. (2010) Virus-like particles in vaccine development. Expert Review of Vaccines 9:10, 1149-1176
CrossRef150
A.S. Ihloff, C. Petersen, M. Hoffmann, R. Knecht, S. Tribius. (2010) Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy. Oral Oncology 46:10, 705-711
CrossRef151
Emily J. Lo, Diana Bell, Jason S. Woo, Guojun Li, Ehab Y. Hanna, Adel K. El-Naggar, Erich M. Sturgis. (2010) Human papillomavirus and WHO type I nasopharyngeal carcinoma. The Laryngoscope 120:10, 1990-1997
CrossRef152
Andrew G. Shuman, Gregory T. Wolf. (2010) Human papillomavirus status in head and neck cancer. Cancer 116:18, 4221-4226
CrossRef153
M. Evans, N.G. Powell. (2010) The Changing Aetiology of Head and Neck Cancer: the Role of Human Papillomavirus. Clinical Oncology 22:7, 538-546
CrossRef154
Emily Crozier, Baran D. Sumer. (2010) Head and Neck Cancer. Medical Clinics of North America 94:5, 1031-1046
CrossRef155
Mark W. Lingen. (2010) Can saliva-based HPV tests establish cancer risk and guide patient management?. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 110:3, 273-274
CrossRef156
Jon Mork, Bjørn Møller, Tove Dahl, Freddie Bray. (2010) Time trends in pharyngeal cancer incidence in Norway 1981–2005: a subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes & Control 21:9, 1397-1405
CrossRef157
Clint T. Allen, James S. Lewis, Samir K. El-Mofty, Bruce H. Haughey, Brian Nussenbaum. (2010) Human papillomavirus and oropharynx cancer: Biology, detection and clinical implications. The Laryngoscope 120:9, 1756-1772
CrossRef158
Mario A. Brondani, Mario A. Cruz-Cabrera, Cheryle Colombe. (2010) Oral sex and oral cancer in the context of human papillomavirus infection: lay public understanding. Oncology Reviews 4:3, 171-176
CrossRef159
Elaine M. Smith, Linda M. Rubenstein, Thomas H. Haugen, Eva Hamsikova, Lubomir P. Turek. (2010) Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes & Control 21:9, 1369-1378
CrossRef160
Jiang Hai-rong, Wang Peng, Li Yong, Ning Tao, Rao Xiao-song, Liu Bao-guo. (2010) Detection of human papilloma virus type 16 E6 mRNA in laryngeal squamous cell carcinoma by in situ hybridization. Chinese Journal of Cancer Research 22:3, 218-223
CrossRef161
Joseph Rohrer, Beverly R. K. Wuertz, Frank Ondrey. (2010) Cigarette smoke condensate induces nuclear factor kappa-b activity and proangiogenic growth factors in aerodigestive cells. The Laryngoscope 120:8, 1609-1613
CrossRef162
James S. Lewis, Wade L. Thorstad, Rebecca D. Chernock, Bruce H. Haughey, James H. Yip, Qin Zhang, Samir K. El-Mofty. (2010) p16 Positive Oropharyngeal Squamous Cell Carcinoma:An Entity With a Favorable Prognosis Regardless of Tumor HPV Status. The American Journal of Surgical Pathology 34:8, 1088-1096
CrossRef163
Shanthi Marur, Gypsyamber D'Souza, William H Westra, Arlene A Forastiere. (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. The Lancet Oncology 11:8, 781-789
CrossRef164
Christof Röösli, Gabriela Studer, Sandro J. Stoeckli. (2010) Salvage treatment for recurrent oropharyngeal squamous cell carcinoma. Head & Neck 32:8, 989-996
CrossRef165
Margaret R. Wallace, Henrietta Logan, Christine Orlando, William Mendenhall, Deborah M. Herbstman, Brandon Sack, Donghong Wang, Elaine M. Smith. (2010) HPV in Head and Neck Cancers Among 5-Year Survivors. American Journal of Clinical Oncology 33:4, 425-426
CrossRef166
M.E. Bellón Guardia, L. Pérez Romasanta, A.M. García Vicente, M.P. Talavera Rubio, A. Palomar Muñoz, B. González García, V.M. Poblete García, A. Soriano Castrejón. (2010) Utilidad de la PET-TAC en la planificación radioterápica en el cáncer de cabeza y cuello. Nuestra experiencia inicial. Revista Española de Medicina Nuclear 29:4, 157-164
CrossRef167
Rebecca D. Chernock, James S. Lewis, Qin Zhang, Samir K. El-Mofty. (2010) Human papillomavirus–positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. Human Pathology 41:7, 1016-1023
CrossRef168
Max Robinson, Philip Sloan, Richard Shaw. (2010) Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncology 46:7, 492-496
CrossRef169
Edward B. Stelow, Vickie Y. Jo, Mark H. Stoler, Stacey E. Mills. (2010) Human Papillomavirus-associated Squamous Cell Carcinoma of the Upper Aerodigestive Tract. The American Journal of Surgical Pathology 34:7, e15-e24
CrossRef170
Marilena Vered, Dan Dayan, Alex Dobriyan, Ran Yahalom, Bruria Shalmon, Iris Barshack, Lev Bedrin, Yoav P. Talmi, Shlomo Taicher. (2010) Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. Journal of Cancer Research and Clinical Oncology 136:7, 1039-1048
CrossRef171
Jill Koshiol, Wen-Qiang Wei, Aimee R. Kreimer, Wen Chen, Patti Gravitt, Jian-Song Ren, Christian C. Abnet, Jian-Bing Wang, Farin Kamangar, Dong-Mei Lin, Magnus von Knebel-Doeberitz, Yu Zhang, Raphael Viscidi, Guo-Qing Wang, Maura L. Gillison, Mark J. Roth, Zhi-Wei Dong, Esther Kim, Philip R. Taylor, You-Lin Qiao, Sanford M. Dawsey. (2010) No role for human papillomavirus in esophageal squamous cell carcinoma in China. International Journal of Cancer 127:1, 93-100
CrossRef172
Michael S. McLemore, Missak Haigentz, Richard V. Smith, Gerard J. Nuovo, Llucia Alos, Antonio Cardesa, Margaret Brandwein-Gensler. (2010) Head and Neck Squamous Cell Carcinomas in HIV-Positive Patients: A Preliminary Investigation of Viral Associations. Head and Neck Pathology 4:2, 97-105
CrossRef173
Michael P. Carey, Theresa E. Senn, Peter A. Vanable, Patricia Coury-Doniger, Marguerite A. Urban. (2010) Brief and Intensive Behavioral Interventions to Promote Sexual Risk Reduction among STD Clinic Patients: Results from a Randomized Controlled Trial. AIDS and Behavior 14:3, 504-517
CrossRef174
CHRISTEL BRAEMER LAJER, CHRISTIAN VON BUCHWALD. (2010) The role of human papillomavirus in head and neck cancer. APMIS 118:6-7, 510-519
CrossRef175
Saman Warnakulasuriya. (2010) Living with oral cancer: Epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncology 46:6, 407-410
CrossRef176
Jan Klozar, Ruth Tachezy, Eliška Rotnáglová, Eva Košlabová, Martina Saláková, Eva Hamšíková. (2010) Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects. Wiener Medizinische Wochenschrift 160:11-12, 305-309
CrossRef177
Boris Klingenberg, Harriët C Hafkamp, Annick Haesevoets, Johannes J Manni, Pieter J Slootweg, Soenke J Weissenborn, Jens P Klussmann, Ernst-Jan M Speel. (2010) p16INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV. Histopathology 56:7, 957-967
CrossRef178
Pernille Lassen. (2010) The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome. Radiotherapy and Oncology 95:3, 371-380
CrossRef179
Suzanne M. Garland, Jennifer S. Smith. (2010) Human Papillomavirus Vaccines. Drugs 70:9, 1079-1098
CrossRef180
Douglass Chepeha, Avraham Eisbruch. (2010) Commentary: Clinical Nodal Staging of Human Papillomavirus–Related Oropharyngeal Cancer. The Cancer Journal 16:3, 283
CrossRef181
Eugene N. Myers. (2010) Head and neck oncology – 2010, part I. Otolaryngologia Polska 64:3, 136-146
CrossRef182
Margaret Stanley. (2010) Pathology and epidemiology of HPV infection in females. Gynecologic Oncology 117:2, S5-S10
CrossRef183
Anna R. Giuliano, Gabriella Anic, Alan G. Nyitray. (2010) Epidemiology and pathology of HPV disease in males. Gynecologic Oncology 117:2, S15-S19
CrossRef184
Amrit Kaur Sakhi, Siv Kj
lsrud Bhn, Sigbjrn Smeland, Magne Thoresen, Guro Berge Smedshaug, Johan Tausj, Arne Svilaas, Anette Karlsen, Kjell Magne Russnes, Tone Svilaas, Rune Blomhoff. (2010) Postradiotherapy Plasma Lutein, α-Carotene, and β-Carotene Are Positively Associated With Survival in Patients With Head and Neck Squamous Cell Carcinoma. Nutrition and Cancer 62:3, 322-328
CrossRef185
Min-Chi Chen, Wei-Chao Huang, Chunghuang Hubert Chan, Ping-Tsung Chen, Kuan-Der Lee. (2010) Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer. Oral Oncology 46:4, 249-254
CrossRef186
N.P. Nguyen, A. Chi, L.M. Nguyen, B.H. Ly, U. Karlsson, V. Vinh-Hung. (2010) Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. QJM 103:4, 229-236
CrossRef187
Dengfeng Cao, Shahnaz Begum, Syed Z. Ali, William H. Westra. (2010) Expression of p16 in benign and malignant cystic squamous lesions of the neck. Human Pathology 41:4, 535-539
CrossRef188
Joel M. Palefsky. (2010) Human Papillomavirus-Related Disease in Men: Not Just a Women's Issue. Journal of Adolescent Health 46:4, S12-S19
CrossRef189
Kimon Divaris, Andrew F. Olshan, Joanna Smith, Mary E. Bell, Mark C. Weissler, William K. Funkhouser, Patrick T. Bradshaw. (2010) Oral health and risk for head and neck squamous cell carcinoma: the Carolina Head and Neck Cancer Study. Cancer Causes & Control 21:4, 567-575
CrossRef190
Angela M. Hong, Andrew E. Grulich, Deanna Jones, C. Soon Lee, Suzanne M. Garland, Timothy A. Dobbins, Jonathan R. Clark, Gerald B. Harnett, Christopher G. Milross, Christopher J. O’Brien, Barbara R. Rose. (2010) Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 28:19, 3269-3272
CrossRef191
Yu-Chu Wang, Yi-Shan Tsai, Jau-Ling Huang, Ka-Wo Lee, Ching-Chuan Kuo, Chung-Sheng Wang, A-Mei Huang, Jang-Yang Chang, Yuh-Jyh Jong, Chang-Shen Lin. (2010) Arecoline arrests cells at prometaphase by deregulating mitotic spindle assembly and spindle assembly checkpoint: Implication for carcinogenesis. Oral Oncology 46:4, 255-262
CrossRef192
C. Scully, A. Hegarty. 2010. The Oral Cavity and Lips. , 1-129.
CrossRef193
Mihaela Avramut, Susanne M. Gollin. 2010. Tumors of the Upper Aerodigestive Tract. , 375-413.
CrossRef194
Margaret Brandwein-Gensler, Richard V. Smith. (2010) Prognostic Indicators in Head and Neck Oncology Including the New 7th Edition of the AJCC Staging System. Head and Neck Pathology 4:1, 53-61
CrossRef195
Shiwen Peng, Simon R. Best, Chien-Fu Hung, Myriam Loyo, Sofia Lyford-Pike, Paul W. Flint, David E. Tunkel, John R. Saunders, T. C. Wu, Sara I. Pai. (2010) Characterization of human papillomavirus type 11-specific immune responses in a preclinical model. The Laryngoscope 120:3, 504-510
CrossRef196
David J. Adelstein, Cristina P. Rodriguez. (2010) Human Papillomavirus: Changing Paradigms in Oropharyngeal Cancer. Current Oncology Reports 12:2, 115-120
CrossRef197
Elizabeth Bilodeau, Faizan Alawi, Bernard J. Costello, Joanne L. Prasad. (2010) Molecular Diagnostics for Head and Neck Pathology. Oral and Maxillofacial Surgery Clinics of North America 22:1, 183-194
CrossRef198
Kymberlee Montgomery, Joan Rosen Bloch. (2010) The human papillomavirus in women over 40: Implications for practice and recommendations for screening. Journal of the American Academy of Nurse Practitioners 22:2, 92-100
CrossRef199
J. E Heck, J. Berthiller, S. Vaccarella, D. M Winn, E. M Smith, O. Shan'gina, S. M Schwartz, M. P Purdue, A. Pilarska, J. Eluf-Neto, A. Menezes, M. D McClean, E. Matos, S. Koifman, K. T Kelsey, R. Herrero, R. B Hayes, S. Franceschi, V. Wunsch-Filho, L. Fernandez, A. W Daudt, M. P. Curado, C. Chen, X. Castellsague, G. Ferro, P. Brennan, P. Boffetta, M. Hashibe. (2010) Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. International Journal of Epidemiology 39:1, 166-181
CrossRef200
Ha Linh Vu, Andrew G. Sikora, Shibo Fu, Johnny Kao. (2010) HPV-induced oropharyngeal cancer, immune response and response to therapy. Cancer Letters 288:2, 149-155
CrossRef201
Damjan S Nikolic, Vincent Piguet. (2010) Vaccines and Microbicides Preventing HIV-1, HSV-2, and HPV Mucosal Transmission. Journal of Investigative Dermatology 130:2, 352-361
CrossRef202
Gypsyamber D’Souza, Hao H. Zhang, Warren D. D’Souza, Robert R. Meyer, Maura L. Gillison. (2010) Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncology 46:2, 100-104
CrossRef203
Gideon Y. Bachar, Christopher Goh, David P. Goldstein, Brian O’Sullivan, Jonathan C. Irish. (2010) Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy. European Archives of Oto-Rhino-Laryngology 267:2, 295-301
CrossRef204
Eric R. Buhi, Stephanie L. Marhefka, Mary T. Hoban. (2010) The State of the Union: Sexual Health Disparities in a National Sample of US College Students. Journal of American College Health 58:4, 337-346
CrossRef205
K. Thomas Robbins, Stephen B. Howell, James Scott Williams. (2010) Intra-arterial chemotherapy for head and neck cancer. CancerNA-NA
CrossRef206
Per Attner, Juan Du, Anders Näsman, Lalle Hammarstedt, Torbjörn Ramqvist, Johan Lindholm, Linda Marklund, Tina Dalianis, Eva Munck-Wikland. (2010) The role of human papillomavirus in the increased incidence of base of tongue cancer. International Journal of CancerNA-NA
CrossRef207
Andrew E. Grulich, Fengyi Jin, E. Lynne Conway, Alicia N. Stein, Jane Hocking. (2010) Cancers attributable to human papillomavirus infection. Sexual Health 7:3, 244
CrossRef208
Young Kim, Eun-Hui Jeong, Byung-Woo Min, Sung-Sun Kim, Yoo Duk Choi, Woon Jae Jung, Jong-Hee Nam, Chang Soo Park. (2010) HPV Genotyping in Squamous Cell Carcinoma of Upper Aerodigestive Tract. The Korean Journal of Pathology 44:5, 483
CrossRef209
Pernille Lassen, Jesper Grau Eriksen, Stephen Hamilton-Dutoit, Trine Tramm, Jan Alsner, Jens Overgaard. (2010) HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiotherapy and Oncology 94:1, 30-35
CrossRef210
Alain C. Jung, Jenny Briolat, Régine Millon, Aurélien de Reyniès, David Rickman, Emilie Thomas, Joseph Abecassis, Christine Clavel, Bohdan Wasylyk. (2010) Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. International Journal of CancerNA-NA
CrossRef211
Aimée R. Kreimer, Rohini K. Bhatia, Andrea L. Messeguer, Paula González, Rolando Herrero, Anna R. Giuliano. (2010) Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the Literature. Sexually Transmitted Diseases1
CrossRef212
Aatur D. Singhi, William H. Westra. (2010) Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. CancerNA-NA
CrossRef213
Rita S. Axelrod. (2009) Introduction: Women and Lung Cancer. Seminars in Oncology 36:6, 504-505
CrossRef214
Missak Haigentz, Carl E. Silver, June Corry, Eric M. Genden, Robert P. Takes, Alessandra Rinaldo, Alfio Ferlito. (2009) Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. European Archives of Oto-Rhino-Laryngology 266:12, 1845-1855
CrossRef215
Yao-Jen Li, Yu-Chin Tsai, Yen-Ching Chen, David C. Christiani. (2009) Human Papilloma Virus and Female Lung Adenocarcinoma. Seminars in Oncology 36:6, 542-552
CrossRef216
E. J. Kwak, K. Julian, . (2009) Human Papillomavirus Infection in Solid Organ Transplant Recipients. American Journal of Transplantation 9, S151-S160
CrossRef217
S. Warnakulasuriya. (2009) Causes of oral cancer – an appraisal of controversies. BDJ 207:10, 471-475
CrossRef218
Gayani Pitiyage, W. M. Tilakaratne, Mahvash Tavassoli, Saman Warnakulasuriya. (2009) Molecular markers in oral epithelial dysplasia: review. Journal of Oral Pathology & Medicine 38:10, 737-752
CrossRef219
Andrew M. Bellizzi, Randall L. Woodford, Christopher A. Moskaluk, David R. Jones, Benjamin D. Kozower, Edward B. Stelow. (2009) Basaloid Squamous Cell Carcinoma of the Esophagus: Assessment for High-risk Human Papillomavirus and Related Molecular Markers. The American Journal of Surgical Pathology 33:11, 1608-1614
CrossRef220
Boudewijn J.M. Braakhuis, Ruud H. Brakenhoff, Chris J.L.M. Meijer, Peter J.F. Snijders, C. René Leemans. (2009) Human papilloma virus in head and neck cancer: The need for a standardised assay to assess the full clinical importance. European Journal of Cancer 45:17, 2935-2939
CrossRef221
Shlok Gupta, Weidong Kong, Yingwei Peng, Qun Miao, William J. Mackillop. (2009) Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States. International Journal of Cancer 125:9, 2159-2165
CrossRef222
Y. Deleré. (2009) Die Impfung gegen HPV. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 52:11, 1065-1068
CrossRef223
Christine G. Gourin, Jonas T. Johnson. (2009) A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the head and neck. The Laryngoscope 119:11, 2124-2134
CrossRef224
A. Martorell-Calatayud, R. Botella-Estrada, J.V. Bagán-Sebastián, O. Sanmartín-Jiménez, C. Guillén-Barona. (2009) La leucoplasia oral: definición de parámetros clínicos, histopatológicos y moleculares y actitud terapéutica. Actas Dermo-Sifiliográficas 100:8, 669-684
CrossRef225
Payal C. Desai, Michael V. Jaglal, Purva Gopal, Shin-Je Ghim, Donald M. Miller, Hanan Farghaly, Alfred B. Jenson. (2009) Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: A retrospective 7 year study. Experimental and Molecular Pathology 87:2, 94-98
CrossRef226
Alice Che-Ha Chen, Annie Keleher, Mary-Anne Kedda, Amanda B. Spurdle, Nigel A.J. McMillan, Annika Antonsson. (2009) Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. Journal of Medical Virology 81:10, 1792-1796
CrossRef227
William M. Mendenhall, Henrietta L. C. Logan. (2009) Human Papillomavirus and Head and Neck Cancer. American Journal of Clinical Oncology 32:5, 535-539
CrossRef228
P.A. Hudgins, M. Gillison. (2009) Second Branchial Cleft Cyst: NOT!!. American Journal of Neuroradiology 30:9, 1628-1629
CrossRef229
Simon R. Best, Shiwen Peng, Chi-Mou Juang, Chien-Fu Hung, Drew Hannaman, John R. Saunders, T.-C. Wu, Sara I. Pai. (2009) Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 27:40, 5450-5459
CrossRef230
Rebecca D. Chernock, Samir K. El-Mofty, Wade L. Thorstad, Curtis A. Parvin, James S. Lewis. (2009) HPV-Related Nonkeratinizing Squamous Cell Carcinoma of the Oropharynx: Utility of Microscopic Features in Predicting Patient Outcome. Head and Neck Pathology 3:3, 186-194
CrossRef231
C Scully, JV Bagan. (2009) Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Diseases 15:6, 388-399
CrossRef232
Boudewijn J.M. Braakhuis, Otto Visser, C. René Leemans. (2009) Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults. Oral Oncology 45:9, e85-e89
CrossRef233
Maura L Gillison. (2009) Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Current Opinion in Oncology 21:5, 439-444
CrossRef234
R.T.D. Oliver. (2009) CIRCUMCISION AND/OR VACCINATION AGAINST HUMAN PAPILLOMAVIRUS IN THE MALE TO PREVENT INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS: AN EARLY SURROGATE ENDPOINT FOR THE LATER PREVENTION OF PENILE, PROSTATE, ANAL AND ORAL CANCER?. BJU International 104:6, 753-755
CrossRef235
O. Matzinger, A. Zouhair, R.O. Mirimanoff, M. Ozsahin. (2009) Radiochemotherapy in Locally Advanced Squamous Cell Carcinomas of the Head and Neck. Clinical Oncology 21:7, 525-531
CrossRef236
A. K. Chaturvedi, M. M. Madeleine, R. J. Biggar, E. A. Engels. (2009) Risk of Human Papillomavirus-Associated Cancers Among Persons With AIDS. JNCI Journal of the National Cancer Institute 101:16, 1120-1130
CrossRef237
Ahmad R. Sedaghat, Zhe Zhang, Shahnaz Begum, Robert Palermo, Simon Best, Karen M. Ulmer, Marshall Levine, Eva Zinreich, Barbara P. Messing, Dorothy Gold, Annie A. Wu, Kevin J. Niparko, Jeanne Kowalski, Richard M. Hirata, John R. Saunders, William H. Westra, Sara I. Pai. (2009) Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. The Laryngoscope 119:8, 1542-1549
CrossRef238
Anders Näsman, Per Attner, Lalle Hammarstedt, Juan Du, Mathilda Eriksson, Geraldine Giraud, Sofie Ährlund-Richter, Linda Marklund, Mircea Romanitan, David Lindquist, Torbjörn Ramqvist, Johan Lindholm, Pär Sparén, Weimin Ye, Hanna Dahlstrand, Eva Munck-Wikland, Tina Dalianis. (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?. International Journal of Cancer 125:2, 362-366
CrossRef239
Anjali K. Gupta, John H. Lee, Werner W. Wilke, Harry Quon, Gareth Smith, Amit Maity, John M. Buatti, Douglas R. Spitz. (2009) Radiation Response in Two HPV-Infected Head-and-Neck Cancer Cell Lines in Comparison to a Non–HPV-Infected Cell Line and Relationship to Signaling Through AKT. International Journal of Radiation Oncology*Biology*Physics 74:3, 928-933
CrossRef240
Llucia Alos, Susana Moyano, Alfons Nadal, Isam Alobid, Jose L. Blanch, Edgar Ayala, Belén Lloveras, Wim Quint, Antonio Cardesa, Jaume Ordi. (2009) Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer 115:12, 2701-2709
CrossRef241
Christina S. Kong, Balasubramanian Narasimhan, Hongbin Cao, Shirley Kwok, Julianna P. Erickson, Albert Koong, Nader Pourmand, Quynh-Thu Le. (2009) The Relationship Between Human Papillomavirus Status and Other Molecular Prognostic Markers in Head and Neck Squamous Cell Carcinomas. International Journal of Radiation Oncology*Biology*Physics 74:2, 553-561
CrossRef242
Elizabeth Andrews, William T. Seaman, Jennifer Webster-Cyriaque. (2009) Oropharyngeal carcinoma in non-smokers and non-drinkers: A role for HPV. Oral Oncology 45:6, 486-491
CrossRef243
Jay S. Cooper, Kim Porter, Katherine Mallin, Henry T. Hoffman, Randal S. Weber, Kian K. Ang, E. Greer Gay, Corey J. Langer. (2009) National Cancer Database report on cancer of the head and neck: 10-Year update. Head & Neck 31:6, 748-758
CrossRef244
Sharmistha DEBANTH, Premala Anthony SINGH, Ravi MEHROTRA, Mangal SINGH, Subhash Chandra GUPTA, Shruti PANDYA, Ajay CHOWDHURY, Mamta SINGH. (2009) Human papillomavirus infection and premalignant lesions of the oral cavity: A cross-sectional study in Allahabad, North India. Asia-Pacific Journal of Clinical Oncology 5:2, 111-118
CrossRef245
Ruth Tachezy, Jan Klozar, Linda Rubenstein, Elaine Smith, Martina Saláková, Jana Šmahelová, Viera Ludvíková, Eliška Rotnáglová, Roman Kodet, Eva Hamšíková. (2009) Demographic and risk factors in patients with head and neck tumors. Journal of Medical Virology 81:5, 878-887
CrossRef246
Kathryn A Gold, Edward S Kim. (2009) Role of molecular markers and gene profiling in head and neck cancers. Current Opinion in Oncology 21:3, 206-211
CrossRef247
Amanda Psyrri, Panagiotis Gouveris, Jan Baptist Vermorken. (2009) Human papillomavirus-related head and neck tumors: clinical and research implication. Current Opinion in Oncology 21:3, 201-205
CrossRef248
Michael D. Greene. (2009) Diagnosis and management of HPV-related anal dysplasia. The Nurse Practitioner 34:5, 45-51
CrossRef249
Maria Paula Curado, Mia Hashibe. (2009) Recent changes in the epidemiology of head and neck cancer. Current Opinion in Oncology 21:3, 194-200
CrossRef250
Sarah L Scarpace, Frank A Brodzik, Syed Mehdi, Robert Belgam. (2009) Treatment of Head and Neck Cancers: Issues for Clinical Pharmacists. Pharmacotherapy 29:5, 578-592
CrossRef251
Saman Warnakulasuriya. (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncology 45:4-5, 309-316
CrossRef252
Wilko Weichert, Christiane Schewe, Carsten Denkert, Lars Morawietz, Manfred Dietel, Iver Petersen. (2009) Molecular HPV Typing as a Diagnostic Tool to Discriminate Primary From Metastatic Squamous Cell Carcinoma of the Lung. The American Journal of Surgical Pathology 33:4, 513-520
CrossRef253
Christian Melle, Günther Ernst, Robert Winkler, Bettina Schimmel, Jens Peter Klussmann, Claus Wittekindt, Orlando Guntinas-Lichius, Ferdinand von Eggeling. (2009) Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: Identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue. PROTEOMICS 9:8, 2193-2201
CrossRef254
Paolo Boscolo-Rizzo, Maria Cristina Da Mosto, Roberto Fuson, Helena Frayle-Salamanca, Rossana Trevisan, Annarosa Del Mistro. (2009) HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. Journal of Cancer Research and Clinical Oncology 135:4, 559-566
CrossRef255
Joel B Epstein, Pelin Güneri. (2009) The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Current Opinion in Otolaryngology & Head and Neck Surgery 17:2, 79-87
CrossRef256
Chad A. Glazer, Steven S. Chang, Patrick K. Ha, Joseph A. Califano. (2009) Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncology 45:4-5, 440-446
CrossRef257
Renaud Mazeron, Yungan Tao, Antoine Lusinchi, Jean Bourhis. (2009) Current concepts of management in radiotherapy for head and neck squamous-cell cancer. Oral Oncology 45:4-5, 402-408
CrossRef258
R Czerninski, S Krichevsky, Y Ashhab, D Gazit, V Patel, D Ben-Yehuda. (2009) Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Diseases 15:3, 206-213
CrossRef259
Crispian Scully, Jose Bagan. (2009) Oral squamous cell carcinoma overview. Oral Oncology 45:4-5, 301-308
CrossRef260
T. Rampias, C. Sasaki, P. Weinberger, A. Psyrri. (2009) E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells. JNCI Journal of the National Cancer Institute 101:6, 412-423
CrossRef261
Christof Röösli, Dominique C. Tschudi, Gabriela Studer, Julia Braun, Sandro J. Stoeckli. (2009) Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx. The Laryngoscope 119:3, 534-540
CrossRef262
Carlo La Vecchia. (2009) Mouthwash and oral cancer risk: An update. Oral Oncology 45:3, 198-200
CrossRef263
Massimo Rittà, Marco De Andrea, Michele Mondini, Jasenka Mazibrada, Carlo Giordano, Giancarlo Pecorari, Massimiliano Garzaro, Vincenzo Landolfo, Marina Schena, Luigi Chiusa, Santo Landolfo. (2009) Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head & Neck 31:3, 318-327
CrossRef264
Leeor Sommer, Doron D. Sommer, David P. Goldstein, Jonathan C. Irish. (2009) Patient perception of risk factors in head and neck cancer. Head & Neck 31:3, 355-360
CrossRef265
William H. Westra. (2009) The Changing Face of Head and Neck Cancer in the 21st Century: The Impact of HPV on the Epidemiology and Pathology of Oral Cancer. Head and Neck Pathology 3:1, 78-81
CrossRef266
Maria Cristina Da Mosto, Federica Zanetti, Paolo Boscolo-Rizzo. (2009) Pattern of lymph node metastases in squamous cell carcinoma of the tonsil: Implication for selective neck dissection. Oral Oncology 45:3, 212-217
CrossRef267
N. Kiyota, M. Tahara, S. Kadowaki, N. Fuse, T. Doi, H. Minami, A. Ohtsu. (2009) Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan. Japanese Journal of Clinical Oncology 39:4, 225-230
CrossRef268
J.P. Klussmann, S.F. Preuss, E.J. Speel. (2009) Humane Papillomviren und Oropharynxkarzinome. HNO 57:2, 113-122
CrossRef269
Sara I. Pai, William H. Westra. (2009) Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment. Annual Review of Pathology: Mechanisms of Disease 4:1, 49-70
CrossRef270
Theresa B. Kim, Harvey Z. Klein, Christine M. Glastonbury, David W. Eisele, Russell B. Smith. (2009) Primary squamous cell carcinoma of Stensen's duct in a patient with HIV: The role of magnetic resonance imaging and fine-needle aspiration. Head & Neck 31:2, 278-282
CrossRef271
Umamaheswar Duvvuri, Jeffrey N. Myers. (2009) Contemporary Management of Oropharyngeal Cancer. Current Problems in Surgery 46:2, 119-184
CrossRef272
Kaalan Johnson, Craig Derkay. (2009) Palliative Aspects of Recurrent Respiratory Papillomatosis. Otolaryngologic Clinics of North America 42:1, 57-70
CrossRef273
Harald zur Hausen. (2009) Papillomaviruses in the causation of human cancers — a brief historical account. Virology 384:2, 260-265
CrossRef274
S. Rajendra, I.K. Robertson. (2009) Barrett's oesophagus; acid and the human papilloma virus?. Journal of Clinical Virology 44:2, 176
CrossRef275
Sarah Morgan, Jennifer R. Grandis. (2009) ErbB receptors in the biology and pathology of the aerodigestive tract. Experimental Cell Research 315:4, 572-582
CrossRef276
Jørgen Slots. (2009) Oral viral infections of adults. Periodontology 2000 49:1, 60-86
CrossRef277
Claude A. Fischer, Inti Zlobec, Edith Green, Simone Probst, Claudio Storck, Alessandro Lugli, Luigi Tornillo, Markus Wolfensberger, Luigi M. Terracciano. (2009) Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?. International Journal of CancerNA-NA
CrossRef278
Kristi L. Bennett, Walter Lee, Eric Lamarre, Xiatong Zhang, Rahul Seth, Joseph Scharpf, Jennifer Hunt, Charis Eng. (2009) HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18 , EBF3 , IRX1 , and SEPT9 , but not SLC5A8 , in head and neck squamous cell carcinomas. Genes, Chromosomes and CancerNA-NA
CrossRef279
Quynh-Thu Le, David Raben. (2009) Integrating Biologically Targeted Therapy in Head and Neck Squamous Cell Carcinomas. Seminars in Radiation Oncology 19:1, 53-62
CrossRef280
Alexander D. Rapidis, Gregory T. Wolf. (2009) Immunotherapy of Head and Neck Cancer: Current and Future Considerations. Journal of Oncology 2009, 1-11
CrossRef281
Joel Palefsky. (2009) Human papillomavirus-related disease in people with HIV. Current Opinion in HIV and AIDS 4:1, 52-56
CrossRef282
Wing Leung. (2009) Immunotherapy in Acute Leukemia. Seminars in Hematology 46:1, 89-99
CrossRef283
M. Stanley. (2008) HPV vaccines: are they the answer?. British Medical Bulletin 88:1, 59-74
CrossRef284
Michael E. Stadler, Mihir R. Patel, Marion E. Couch, David Neil Hayes. (2008) Molecular Biology of Head and Neck Cancer: Risks and Pathways. Hematology/Oncology Clinics of North America 22:6, 1099-1124
CrossRef285
Thomas K. Hoffmann, Eniko Sonkoly, Ulrich Hauser, Anke van Lierop, Theresa L. Whiteside, Jens Peter Klussmann, Dieter Hafner, Patrick Schuler, Ulrike Friebe-Hoffmann, Kathrin Scheckenbach, Kaisa Erjala, Reidar Grénman, Jörg Schipper, Henning Bier, Vera Balz. (2008) Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncology 44:12, 1100-1109
CrossRef286
Laura Vidal, Maura L. Gillison. (2008) Human Papillomavirus in HNSCC: Recognition of a Distinct Disease Type. Hematology/Oncology Clinics of North America 22:6, 1125-1142
CrossRef287
Lisa Licitra, Giulia Zigon, Gemma Gatta, Maria-José Sánchez, Franco Berrino. (2008) Human Papillomavirus in HNSCC: A European Epidemiologic Perspective. Hematology/Oncology Clinics of North America 22:6, 1143-1153
CrossRef288
Scott M. Lippman. (2008) The Future of Molecular-Targeted Cancer Chemoprevention. Gastroenterology 135:6, 1834-1841
CrossRef289
Thomas Q Gallagher, Craig S Derkay. (2008) Recurrent respiratory papillomatosis: update 2008. Current Opinion in Otolaryngology & Head and Neck Surgery 16:6, 536-542
CrossRef290
H. J. T. van Zeeburg, P. J. F. Snijders, T. Wu, E. Gluckman, J. Soulier, J. Surralles, M. Castella, J. E. van der Wal, J. Wennerberg, J. Califano, E. Velleuer, R. Dietrich, W. Ebell, E. Bloemena, H. Joenje, C. R. Leemans, R. H. Brakenhoff. (2008) Clinical and Molecular Characteristics of Squamous Cell Carcinomas From Fanconi Anemia Patients. JNCI Journal of the National Cancer Institute 100:22, 1649-1653
CrossRef291
Robert D. Alston, Marco Geraci, Tim O. B. Eden, Anthony Moran, Steve Rowan, Jillian M. Birch. (2008) Changes in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979-2003. Cancer 113:10, 2807-2815
CrossRef292
A. Blythe Ryerson, Edward S. Peters, Steven S. Coughlin, Vivien W. Chen, Maura L. Gillison, Marsha E. Reichman, Xiaocheng Wu, Anil K. Chaturvedi, Kelly Kawaoka. (2008) Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 113:S10, 2901-2909
CrossRef293
Maura L. Gillison, Anil K. Chaturvedi, Douglas R. Lowy. (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113:S10, 3036-3046
CrossRef294
C. S. Furniss, M. D. McClean, J. F. Smith, J. Bryan, K. M. Applebaum, H. H. Nelson, M. R. Posner, K. T. Kelsey. (2008) Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use. Annals of Oncology 20:3, 534-541
CrossRef295
Maura L. Gillison. (2008) Human Papillomavirus-Related Diseases: Oropharynx Cancers and Potential Implications for Adolescent HPV Vaccination. Journal of Adolescent Health 43:4, S52-S60
CrossRef296
N. Rai, G.J.S. Jenkins, E. McAdam, S.J. Hibbitts, A.N. Fiander, N.G. Powell. (2008) Human papillomavirus infection in Barrett's oesophagus in the UK: An infrequent event. Journal of Clinical Virology 43:2, 250-252
CrossRef297
Birger Trollfors. (2008) Human papillomavirus vaccines: an outsider’s point of view. Expert Review of Vaccines 7:8, 1131-1133
CrossRef298
Karin L. Richter, Estrelita Janse Van Rensburg, Willie F. P. Van Heerden, Sonja C. Boy. (2008) Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy. Journal of Oral Pathology & Medicine 37:9, 555-559
CrossRef299
Daron G. Ferris, Jennifer L. Waller, Jeremiah Miller, Pratik Patel, Lanier Jackson, George A. Price, Courtesia Wilson. (2008) Men's Attitudes Toward Receiving the Human Papillomavirus Vaccine. Journal of Lower Genital Tract Disease 12:4, 276-281
CrossRef300
Anna-Barbara Moscicki. (2008) HPV Vaccines: Today and in the Future. Journal of Adolescent Health 43:4, S26-S40
CrossRef301
David M. Cognetti, Randal S. Weber, Stephen Y. Lai. (2008) Head and neck cancer. Cancer 113:S7, 1911-1932
CrossRef302
Haddad, Robert I., Shin, Dong M., . (2008) Recent Advances in Head and Neck Cancer. New England Journal of Medicine 359:11, 1143-1154
Full Text303
Samir K. El-Mofty, Megan Q. Zhang, Rosa M. Davila. (2008) Histologic Identification of Human Papillomavirus (HPV)-Related Squamous Cell Carcinoma in Cervical Lymph Nodes: A Reliable Predictor of the Site of an Occult Head and Neck Primary Carcinoma. Head and Neck Pathology 2:3, 163-168
CrossRef304
Mario Brondani. (2008) HPV, oral sex, and the risk of oral cancer: food for thought. Special Care in Dentistry 28:5, 183-184
CrossRef305
Bipin N. Savani, Pamela Stratton, Aarthi Shenoy, Eleftheria Kozanas, Stacey Goodman, A. John Barrett. (2008) Increased Risk of Cervical Dysplasia in Long-Term Survivors of Allogeneic Stem Cell Transplantation—Implications for Screening and HPV Vaccination. Biology of Blood and Marrow Transplantation 14:9, 1072-1075
CrossRef306
Elizabeth A Stier, Amy S Baranoski. (2008) Human papillomavirus-related diseases in HIV-infected individuals. Current Opinion in Oncology 20:5, 541-546
CrossRef307
Mark W. Lingen. (2008) The changing face of head and neck cancer. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 106:3, 315-316
CrossRef308
Anna R. Giuliano, Guillermo Tortolero-Luna, Elena Ferrer, Ann N. Burchell, Silvia de Sanjose, Susanne Kruger Kjaer, Nubia Muñoz, Mark Schiffman, F. Xavier Bosch. (2008) Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions. Vaccine 26, K17-K28
CrossRef309
Gypsyamber DʼSouza, Dorothy J Wiley, Xiuhong Li, Joan S Chmiel, Joseph B Margolick, Ross D Cranston, Lisa P Jacobson. (2008) Incidence and Epidemiology of Anal Cancer in the Multicenter AIDS Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 48:4, 491-499
CrossRef310
Myriam Loyo, Sara I. Pai. (2008) The Molecular Genetics of Laryngeal Cancer. Otolaryngologic Clinics of North America 41:4, 657-672
CrossRef311
Robert Haddad, Christopher Crum, Zigui Chen, Jeffrey Krane, Marshall Posner, Yi Li, Robert Burk. (2008) HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncology 44:8, 812-815
CrossRef312
Jennifer E. Cameron, Michael E. Hagensee. (2008) Oral HPV complications in HIV-infected patients. Current HIV/AIDS Reports 5:3, 126-131
CrossRef313
Shanaz Begum, William H. Westra. (2008) Basaloid Squamous Cell Carcinoma of the Head and Neck is a Mixed Variant That Can be Further Resolved by HPV Status. The American Journal of Surgical Pathology 32:7, 1044-1050
CrossRef314
Bhuvanesh Singh. (2008) Molecular pathogenesis of head and neck cancers. Journal of Surgical Oncology 97:8, 634-639
CrossRef315
Arlene A. Forastiere. (2008) Chemotherapy in the treatment of locally advanced head and neck cancer. Journal of Surgical Oncology 97:8, 701-707
CrossRef316
Steven S. Chang, Joseph Califano. (2008) Current status of biomarkers in head and neck cancer. Journal of Surgical Oncology 97:8, 640-643
CrossRef317
Johnny Kao, Amir Lavaf, Marita S. Teng, Delphine Huang, Eric M. Genden. (2008) Adjuvant Radiotherapy and Survival for Patients With Node-Positive Head and Neck Cancer: An Analysis by Primary Site and Nodal Stage. International Journal of Radiation Oncology*Biology*Physics 71:2, 362-370
CrossRef318
Kevin T. Palka, Robbert J. Slebos, Christine H. Chung. (2008) Update on Molecular Diagnostic Tests in Head and Neck Cancer. Seminars in Oncology 35:3, 198-210
CrossRef319
Christine M. Huang. (2008) Human Papillomavirus and Vaccination. Mayo Clinic Proceedings 83:6, 701-707
CrossRef320
Cornelia L Trimble, Patti Gravitt, Richard BS Roden. (2008) Human papillomavirus screening and vaccines for cancer prevention: what is on the horizon?. Therapy 5:3, 295-303
CrossRef321
Athanassios Argiris, Michalis V Karamouzis, David Raben, Robert L Ferris. (2008) Head and neck cancer. The Lancet 371:9625, 1695-1709
CrossRef322
Shehnaz K. Hussain, Jan Sundquist, Kari Hemminki. (2008) Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish Family-Cancer Database. International Journal of Cancer 122:8, 1873-1878
CrossRef323
Aron Popovtzer, Avraham Eisbruch. (2008) Advances in radiation therapy of head and neck cancer. Expert Review of Anticancer Therapy 8:4, 633-644
CrossRef324
Shanthi Marur, Arlene A. Forastiere. (2008) Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment. Mayo Clinic Proceedings 83:4, 489-501
CrossRef325
M. L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, S. Begum, R. Viscidi. (2008) Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers. JNCI Journal of the National Cancer Institute 100:6, 407-420
CrossRef326
Esther M. O'Regan, Mary E. Toner, Stephen P. Finn, Chun Yang Fan, Martina Ring, Bjorn Hagmar, Conrad Timon, Paul Smyth, Susanne Cahill, Richard Flavin, Orla M. Sheils, John J. O'Leary. (2008) p16INK4A genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Human Pathology 39:3, 452-458
CrossRef327
Mostafa Nokta. (2008) Oral manifestations associated with HIV infection. Current HIV/AIDS Reports 5:1, 5-12
CrossRef328
William Dynan, Yoshihiko Takeda, David Roth, Gang Bao. (2008) Understanding and re-engineering nucleoprotein machines to cure human disease. Nanomedicine 3:1, 93-105
CrossRef329
Gabriela Anaya-Saavedra, Velia Ramírez-Amador, Ma. Esther Irigoyen-Camacho, Claudia Ma. García-Cuellar, Miriam Guido-Jiménez, Rocío Méndez-Martínez, Alejandro García-Carrancá. (2008) High Association of Human Papillomavirus Infection with Oral Cancer: A Case-Control Study. Archives of Medical Research 39:2, 189-197
CrossRef330
Amanda Psyrri, Daniel DiMaio. (2008) Human papillomavirus in cervical and head-and-neck cancer. Nature Clinical Practice Oncology 5:1, 24-31
CrossRef331
B.H. Thiers. (2008) Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer. Yearbook of Dermatology and Dermatologic Surgery 2008, 142-143
CrossRef332
A. Bozec, G. Poissonnet, P. Mahdyoun, O. Dassonville. (2008) C??nceres del piso de la boca. EMC - Otorrinolaringolog??a 37:4, 1-19
CrossRef333
R. Seethala. (2008) Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: Characterization of a distinct phenotype. Yearbook of Pathology and Laboratory Medicine 2008, 209-210
CrossRef334
Katerina Strati, Paul F Lambert. (2008) Human papillomavirus association with head and neck cancers: understanding virus biology and using it in the development of cancer diagnostics. Expert Opinion on Medical Diagnostics 2:1, 11-20
CrossRef335
Jami S. Leichliter, Anjani Chandra, Nicole Liddon, Kevin A. Fenton, Sevgi O. Aral. (2007) Prevalence and Correlates of Heterosexual Anal and Oral Sex in Adolescents and Adults in the United States. The Journal of Infectious Diseases 196:12, 1852-1859
CrossRef336
K. M. Applebaum, C. S. Furniss, A. Zeka, M. R. Posner, J. F. Smith, J. Bryan, E. A. Eisen, E. S. Peters, M. D. McClean, K. T. Kelsey. (2007) Lack of Association of Alcohol and Tobacco with HPV16-Associated Head and Neck Cancer. JNCI Journal of the National Cancer Institute 99:23, 1801-1810
CrossRef337
David Lindquist, Mircea Romanitan, Lalle Hammarstedt, Anders Näsman, Hanna Dahlstrand, Johan Lindholm, Liselotte Onelöv, Torbjörn Ramqvist, Weimin Ye, Eva Munck-Wikland, Tina Dalianis. (2007) Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Molecular Oncology 1:3, 350-355
CrossRef338
Joel A. Ernster, Cosimo G. Sciotto, Maureen M. O’Brien, Jack L. Finch, Linda J. Robinson, Thomas Willson, Michael Mathews. (2007) Rising Incidence of Oropharyngeal Cancer and the Role of Oncogenic Human Papilloma Virus. The Laryngoscope 117:12, 2115-2128
CrossRef339
Serge J. Smeets, Albertus T. Hesselink, Ernst-Jan M. Speel, Annick Haesevoets, Peter J.F. Snijders, Michael Pawlita, Chris J.L.M. Meijer, Boudewijn J.M. Braakhuis, C. René Leemans, Ruud H. Brakenhoff. (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. International Journal of Cancer 121:11, 2465-2472
CrossRef340
J. Sibilia. (2007) Quoi de neuf en médecine en 2007 ?. Annales de Dermatologie et de Vénéréologie 134, 8S24-8S35
CrossRef341
NF Schlecht, RD Burk, L Adrien, A Dunne, N Kawachi, C Sarta, Q Chen, M Brandwein-Gensler, MB Prystowsky, G Childs, RV Smith, TJ Belbin. (2007) Gene expression profiles in HPV-infected head and neck cancer. The Journal of Pathology 213:3, 283-293
CrossRef342
Bradley J. Monk, Krishnansu S. Tewari. (2007) The spectrum and clinical sequelae of human papillomavirus infection. Gynecologic Oncology 107:2, S6-S13
CrossRef343
Ian H. Frazer, Doug R. Lowy, John T. Schiller. (2007) Prevention of cancer through immunization: Prospects and challenges for the 21st century. European Journal of Immunology 37:S1, S148-S155
CrossRef344
Keisuke Shirai, Paul E. O’Brien. (2007) Molecular Targets in Squamous Cell Carcinoma of the Head and Neck. Current Treatment Options in Oncology 8:3, 239-251
CrossRef345
Erich M. Sturgis, Paul M. Cinciripini. (2007) Trends in head and neck cancer incidence in relation to smoking prevalence. Cancer 110:7, 1429-1435
CrossRef346
(2007) Human Papillomavirus and Oropharyngeal Cancer. New England Journal of Medicine 357:11, 1156-1158
Full Text347
Maria Rescigno, Francesca Avogadri, Giuseppe Curigliano. (2007) Challenges and prospects of immunotherapy as cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1776:1, 108-123
CrossRef348
Baden, Lindsey R., Curfman, Gregory D., Morrissey, Stephen, Drazen, Jeffrey M., . (2007) Human Papillomavirus Vaccine — Opportunity and Challenge. New England Journal of Medicine 356:19, 1990-1991
Full Text349
Syrjänen, Stina, . (2007) Human Papillomaviruses in Head and Neck Carcinomas. New England Journal of Medicine 356:19, 1993-1995
Full Text
- Letters
